<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/038828</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;038828</article-id><article-id pub-id-type="other" hwp:sub-type="slug">038828</article-id><article-id pub-id-type="other" hwp:sub-type="tag">038828</article-id><article-version>1.2</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Bioinformatics" hwp:journal="biorxiv"><subject>Bioinformatics</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">sCNAphase: using haplotype resolved read depth to genotype somatic copy number alterations from low cellularity aneuploid tumors</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1">Address correspondence to: Wenhan Chen <email hwp:id="email-1">&lt;wenhan.chen@imb.uq.edu.au</email>&gt;, Lachlan J.M. Coin <email hwp:id="email-2">&lt;l.coin@imb.uq.edu.au&gt;</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" corresp="yes" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Chen Wenhan"><surname>Chen</surname><given-names>Wenhan</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Robertson Alan J."><surname>Robertson</surname><given-names>Alan J.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Ganesamoorthy Devika"><surname>Ganesamoorthy</surname><given-names>Devika</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Coin Lachlan J.M."><surname>Coin</surname><given-names>Lachlan J.M.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">1</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4"><label>1</label><institution hwp:id="institution-1">Institute for Molecular Biosciences</institution>, The University of <country>Queensland</country>.</aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2016"><year>2016</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2016-02-04T14:21:11-08:00">
    <day>4</day><month>2</month><year>2016</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2016-02-09T05:15:21-08:00">
    <day>9</day><month>2</month><year>2016</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2016-02-04T16:26:05-08:00">
    <day>4</day><month>2</month><year>2016</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2016-02-09T09:35:54-08:00">
    <day>9</day><month>2</month><year>2016</year>
  </pub-date><elocation-id>038828</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2016-02-04"><day>04</day><month>2</month><year>2016</year></date>
<date date-type="accepted" hwp:start="2016-02-09"><day>09</day><month>2</month><year>2016</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2016, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2016</copyright-year><license hwp:id="license-1"><p hwp:id="p-1">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="038828.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/038828v2.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="038828.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/038828v2/038828v2.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/038828v2/038828v2.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">Accurate identification of copy number alterations is an essential step in understanding the events driving tumor progression. While a variety of algorithms have been developed to use high-throughput sequencing data to profile copy number changes, no tool is able to reliably characterize ploidy and genotype absolute copy number from tumors which contains less than 40% tumor DNA. To increase our power to resolve the copy number profile of these low cellularity tumor genomes, we developed a novel approach which pre-phases heterozygote germline SNPs in order to replace the commonly used ‘B-allele frequency’ with a more powerful ‘parental-haplotype frequency’. We also describe a novel ‘digital spectral karyotyping’ approach for visualization of copy number alterations.</p><p hwp:id="p-3">We apply our tool - sCNAphase - to characterize the copy number and loss-of-heterozygosity profiles of four publicly available breast cancer cell-lines. Comparisons to previous spectral karyotyping and microarray studies revealed that sCNAphase reliably identified overall ploidy and the individual copy number changes from each cell-line. Analysis of tumor-normal cell-line mixtures demonstrated the capacity of this method to determine the level of tumor purity as little as 5% tumor DNA and to consistently identify sCNAs and characterize ploidy in samples at 10% tumor purity. This novel methodology has the potential to bring sCNA profiling to low-cellularity tumors, a form of cancer unable to be profiled by current methods.</p></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-2">Keywords</title><kwd hwp:id="kwd-1">chromosomal abnormalities</kwd><kwd hwp:id="kwd-2">contamination</kwd><kwd hwp:id="kwd-3">haplotype phasing</kwd><kwd hwp:id="kwd-4">normal</kwd><kwd hwp:id="kwd-5">ploidy</kwd><kwd hwp:id="kwd-6">sCNAphase</kwd><kwd hwp:id="kwd-7">somatic copy number alterations</kwd></kwd-group><counts><page-count count="30"/></counts><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-1">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-3">Introduction</title><p hwp:id="p-4">Somatic Copy Number Alterations (sCNAs) represent an important class of mutation in the cancer genome, evident by the large number of short focal sCNAs and larger chromosomal scale changes seen in the analysis of individual tumor genomes (<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">Beroukhim et al. 2010)</xref>. This class of mutation has been linked to tumor progression, metastasis, multidrug resistance and poor clinical outcomes (<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">Carter et al. 2006</xref>; <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">Sheffer et al. 2009</xref>; <xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">Lee et al. 2011</xref>; <xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">Hieronymus et al. 2014</xref>; <xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">Bambury et al. 2015)</xref>. Despite the sporadic accumulation of sCNAs during tumor progression, a number of regions are subject to recurrent sCNAs (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">Zack et al. 2013)</xref>. Some of these recurrent sCNAs are found across different cancer types, while others were specific to a particular type or subtype of the disease (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">Chin et al. 2006</xref>; <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-2" hwp:rel-id="ref-42">Sheffer et al. 2009</xref>; <xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">Cho et al. 2011</xref>; <xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">Curtis et al. 2012)</xref>. As a result, determining the sCNAs in an individual tumor sample has become standard practice in pathology labs for the treatment of some cancers. For example, this is routinely used to assign the optimal chemotherapeutic treatments for patients with breast cancer who contain additional copies of the <italic toggle="yes">HER2</italic> gene (<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">Bast et al. 2001</xref>; <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">Slamon et al. 2001)</xref>.</p><p hwp:id="p-5">Despite the importance of this class of mutation, it can be difficult to characterize the copy number profile of a tumor genome. Large numbers of invading cells with a normal, diploid genome, such as endothelial or immune cells, can obscure the mutations in the tumor genome (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">Carter et al. 2012)</xref>. These low cellularity samples represent a significant challenge as the best current methods fail to produce the correct results when tumor purity falls below 40% (<bold>Supplementary Table</bold> 1). The tumor purity for a number of serious forms of cancer, such as Breast Invasive Carcinoma, Lung Adenocarcinoma and some forms of Melanoma routinely fall below this threshold, moreover multiple cancers including renal clear cell carcinoma and lower grade glioma show a decreased survival time with lower tumor purity (<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">Aran et al. 2015)</xref>. Thus there is an important unmet need to identify copy number mutations in low purity samples.</p><p hwp:id="p-6">It is possible to survey the copy number profile of samples with a high tumor content, using a number of different techniques, however it is difficult to characterize the full spectrum of sCNAs with a single technology. Spectral Karyotyping (SKY) is one of the most accurate tools for characterizing and visualizing genome wide changes in ploidy (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">Schröck et al. 1996</xref>; <xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">Sirivatanauksorn et al. 2001</xref>; <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">Storlazzi et al. 2010</xref>; <xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">Stephens et al. 2011)</xref>, but suffers from a limited resolution and is low throughput. More recent technologies, such as comparative genomic hybridization (CGH) and single-nucleotide polymorphism (SNP) microarrays have all provided powerful approaches for interrogating the tumor genome and identifying copy number mutations (<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">Zhao et al. 2004</xref>; <xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">Conrad et al. 2010</xref>; <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">Pinto et al. 2011</xref>; <xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">Carter et al. 2012</xref>; <xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">Krijgsman et al. 2014)</xref>. While these approaches have been used effectively to profile sCNAs across a large number of tumor samples, the performance of these tools are restricted by the resolution of different microarray platforms.</p><p hwp:id="p-7">High throughput sequencing (HTS) is a powerful technology for identifying sCNAs, which may make it possible to characterize the complete copy number profile of impure cancer samples. A number of computational tools have been designed to identify copy number changes, characterize loss of heterozygosity (LOH) and identify homozygous deletions, as well as address the challenges posed by stromal cell contamination in tumor samples from HTS data (<bold>Supplementary Table</bold> 1). These tools use a variety of different signals present in HTS data including read depth aberration, B-allele frequency at somatic and germline SNPs. Many of these tools do not address ploidy, and most of them are not suitable for samples with tumor purity less than 40% (<xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">Yau et al. 2010</xref>; <xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">Gusnanto et al. 2012</xref>; <xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">Li and Xie 2014</xref>; <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">Oesper et al. 2014)</xref>. Only Absolute and CNANorm have an explicit parameterization of ploidy in their model. Absolute has been shown to accurately estimate tumor ploidy and purity in tumor cell-line derived tumor-normal mixture samples which contained as little as 40% tumor DNA (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-3" hwp:rel-id="ref-8">Carter et al. 2012)</xref>. CLImAT is a recently introduced tool, which uses read-depth and BAF to estimate the ploidy and purity of impure tumor genomes and also characterizes copy number and LOH changes (<xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">Yu et al. 2014)</xref>. At 20% tumor purity, CLImAT demonstrated more robust purity and ploidy estimates as well as greater sCNA and LOH calling accuracy than Absolute (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-4" hwp:rel-id="ref-8">Carter et al. 2012)</xref>, SNVMix (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">Goya et al. 2010)</xref>, Control-FREEC (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">Boeva et al. 2012)</xref> and Patchwork (<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">Mayrhofer et al. 2013)</xref>, however this was evaluated using simulated tumor chromosomes rather than tumor-normal mixture samples.</p><p hwp:id="p-8">Modelling BAF has strengths and limitations complementary to read-depth (RD) modelling. BAF-which effectively uses an internal control of one allele versus the other - is less susceptible to position-specific biases, such as GC and mappability biases. However, one striking disadvantage of BAF modelling is that it is not possible to directly summate the allelic depth signal over multiple adjacent SNPs, as the non-reference alleles at one adjacent positions may not be on the same parental haplotype. Summating RD over windows of size from 10kb up to 1Mb leads to substantial increases in statistical power to detect sCNAs. We hypothesized that application of state-of-the-art computational phasing approaches, incorporating population haplotype from the 1000 genomes project (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">Altshuler et al. 2012)</xref> as well as direct within-read phasing (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">Delaneau et al. 2013)</xref>, would allow us to sum allelic depth along phased haplotypes to obtain <italic toggle="yes">parental haplotype frequency</italic>(PHF) estimates. We further hypothesized that modelling PHF instead of BAF could lead to improved power characterize tumor ploidy and sCNAs at ultra-low levels of tumor purity.</p><p hwp:id="p-9">In this manuscript we present sCNAphase, a tool, which has been developed to characterize the full copy number profile of a cancer sample across a range of tumor purity. It achieves this by inferring tumor ploidy, sCNAs and regions of LOH across all levels tumor purity by integrated modelling of PHF and RD. We show that sCNAphase has accuracy comparable to SKY in determining genome-wide increases in ploidy and it is able to identify focal sCNAs that are consistent with results from microarray analyzes. We also show that sCNAphase can confidently determine regions that have undergone a loss of heterozygosity event and identify regions of homozygous deletion. Moreover, sCNAphase consistently generates accurate sCNA segmentations at low levels of tumor purity and can accurately define levels of tumor purity in mixtures containing 5% tumor DNA.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-4">Results</title><p hwp:id="p-10">We downloaded high quality sequencing data from eight publicly available, well-characterized cancer cell-lines. These cell-lines were generated from matched tissue samples and represent breast cancer and normal tissue samples from four patients (<xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref>).</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2 xref-table-wrap-1-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-1"><title hwp:id="title-5">Samples included in analysis</title></caption><graphic xlink:href="038828_tbl1" position="float" orientation="portrait" hwp:id="graphic-1"/></table-wrap></sec><sec id="s3" hwp:id="sec-3"><title hwp:id="title-6">Haplotype phasing greatly improves the power to identify sCNA from allelic depth</title><p hwp:id="p-11">The B-allele frequency (BAF) is commonly used to detect the presence of copy number variants (CNVs) in normal, diploid genome(<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">Coin et al. 2010)</xref>. This signal can also be interrogated to find sCNAs by looking for deviations from an expected equal ratio of two alleles at germ-line heterozygous SNPs. In order to investigate the power in this signal, we calculated Allelic Depth (AD) at all germ-line heterozygous SNPs in a tumor derived cell-line (HCC1143, see <xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref>) at varying tumor purities, as well as in the matched normal sample (note that an independent normal was used to generate artificial mixed tumor/normal samples at varying purity, see Methods). The distribution of p-values under a null model which assumes an equal ratio is inflated even for the normal sample, due to the presence of germline CNVs (<bold>Supplementary Figure</bold> 1), thus we instead calculate p-values under the assumption that tumor BAF is the same as germ-line BAF, which corrects this inflation (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1A</xref></bold>). BAF provides substantial power to identify sCNA at 100% purity (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Figure 1B</xref></bold>.), but the signal is too weak at 5% purity to identify any sCNAs (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Figure 1C</xref></bold>.).</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1.</label><caption hwp:id="caption-2"><p hwp:id="p-12">The capacity of different Allele Frequencies to determine sCNAs in tumor derived cell-line samples. Each of the points in the Q-Q plots corresponds to a p-value for a pair of allelic depths from a tumor derived cell line (HCC1143) at all germ-line heterozygote SNPs in different scenarios. The red line represents the expected distribution of p-values under the null hypothesis (of no sCNA). P-values are calculated using a binomial distribution with probability of success equal to observed germline BAF (A, B, C) or PHF (D, E, F). Deviation above this line indicates power to detect sCNA (A) Using BAF on 0% tumor purity sample (i.e. normal). (B) Using BAF at 100% tumor purity (C) Using BAF at 5% tumor purity. (D) Using PHF on a 0% tumor purity sample (i.e. normal). (E) U sing PHF at 100% tumor purity. (F) Using PHF on 5% tumor purity.</p></caption><graphic xlink:href="038828_fig1" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-13">To investigate the improvement in power to detect sCNAs using PHF rather than BAF, we phased germline heterozygotes using SHAPEIT2 (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-2" hwp:rel-id="ref-15">Delaneau et al. 2013)</xref> and the panel of reference haplotypes from the 1000 Genomes Project, then used this information to calculate tumor PHF in no-overlapping windows of 40 consecutive heterozygous SNPs (See methods). This strategy dramatically improved the power to detect sCNAs in the 100% purity sample (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Figure 1E</xref></bold>) and 5% (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Figure 1F</xref></bold>), and did not lead to spurious identification of sCNAs in the normal sample (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Figure 1D</xref></bold>).</p><p hwp:id="p-14">We developed sCNAphase to capitalize on the capacity of the PHF-based approach to characterize copy number profiles at very low tumor purity. This method was designed to integrate PHF (derived from computational phasing) with the total read depth to identify sCNAs, haplotype-specific copy number mutations, estimate the tumor content of a sample and accurately characterize changes in tumor ploidy (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2</xref></bold>).</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5 xref-fig-2-6"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2.</label><caption hwp:id="caption-3"><p hwp:id="p-15">The individual steps that make up the sCNAphase workflow. (A) Each panels shows an individual process used by sCNAphase to characterize the copy number profile from matched tumor and normal pairs. (B) The BAFs from a region of chromosome 8 from the HCC1143 breast cancer cell-line. (C) The application of phasing to the BAF data makes it possible to identify PHFs, regions composed of 40 adjacent germline, heterozygous SNPs. Each PHF increase the power of this analysis and makes it possible to better reflect the copy number profile of this region. ( D) Application of the sCNAphase pipeline to the phased data, calls specific copy number changes.</p></caption><graphic xlink:href="038828_fig2" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-16">In order to characterize the complete copy number profile of a tumor sample, sCNAphase is broken into a number of distinct steps (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Figure 2</xref></bold>). Analysis of the matched normal sample is used to identify heterozygous SNPs present in the germline, these results are passed through SHAPEIT2 (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-3" hwp:rel-id="ref-15">Delaneau et al. 2013)</xref>, a method that uses information from the 1000 Genomes Project to determine the haplotype of each these heterozygous alleles. The allelic depth from groups of 40 of these polymorphic sites are merged to produce a PHF region (90% of PHF regions are &lt; 100kb). This PHF information is first used to estimate the maximum likelihood of a tumor belonging to a specific ploidy, our model examines a larger range of ploidy than other tools, allowing us to characterize samples more complex than a triploid. This ploidy information is used to determine tumor purity and estimate tumor cellularity in an iterative manner. Together this information used to identify the individual copy number changes (Methods).</p><p hwp:id="p-17">Analysis of each of the matched cell-line pairs using sCNAphase revealed that a significant fraction of the genome had been altered by some form of copy number mutation. In some cell-lines, this analysis classified a large amount of the genome as having undergone an LOH event (<xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2"><bold>Table</bold> 2</xref>) such as HCC1143 and HCC1187, interestingly in HCC1143 the majority of these LOH events corresponded to regions that contained two or more copies. These analyses also indicate that each of the cell-lines had seen a significant increase in ploidy.</p><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1 xref-table-wrap-2-2 xref-table-wrap-2-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-4"><p hwp:id="p-18">Summary of results from sCNAphase on 4 cancer cell lines. The proportion of the genome that has undergone sCNA is calculated as the proportion of the genome with copy number not equal to nearest i nteger ploidy.</p></caption><graphic xlink:href="038828_tbl2" position="float" orientation="portrait" hwp:id="graphic-4"/></table-wrap></sec><sec id="s4" hwp:id="sec-4"><title hwp:id="title-7">Digital Spectral Karyotyping with sCNAphase is concordant with spectral karyotyping</title><p hwp:id="p-19">We developed a visualization tool for the output from sCNAphase, which we call <italic toggle="yes">digital spectral karyotyping (dSKY)</italic>, as it generates an image, which is directly comparable to spectral karyotyping (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Figure 3</xref></bold>). These dSKY plots make visual identification of aneuploidy, loss of heterozygosity and focal changes straightforward. To build on SKY platform, red shading on the chromosome ideograms indicates regions of LOH, and green shading indicates double deletions.</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3.</label><caption hwp:id="caption-5"><title hwp:id="title-8">The digital SKY plots from sCNAphase recapitulate the results from SKY analysis</title><p hwp:id="p-20">The dSKY plot from the sCNAphase analysis of HCC1187, as well as the results from an existing SKY analysis of the same cell-line (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">Grigorova et al. 2005)</xref> for each chromosome are shown side by side. While there are some minor differences such as chromosome 9 and 18, the results from these two methods are largely consistent with one another. A yellow box highlights a recurrent, focal amplification on the q arm of chromosome 10.</p></caption><graphic xlink:href="038828_fig3" position="float" orientation="portrait" hwp:id="graphic-5"/></fig><p hwp:id="p-21">dSKY plots generated from the sCNAphase analysis of these cell-lines, were compared to images from existing SKY analyses of the same cell lines (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Figure 3</xref></bold>, <bold>Supplementary Figure</bold> 2) (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-2" hwp:rel-id="ref-20">Grigorova et al. 2005)</xref>. Results from sCNAphase were highly concordant with those from the SKY analysis, both at the level of average ploidy (<xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-2" hwp:rel-id="T2"><bold>Table</bold> 2</xref>) and also in the identification of large-scale genomic alterations. For example, both the sCNAphase and SKY analysis of HCC1187 classified this cell-line as hypo-triploid and identified 4 complete copies of chromosome 7 (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Figure 3</xref></bold>). The higher resolution provided by sCNAphase, reveals more information about the length and the exact location of smaller sCNAs not readily visible by the traditional SKY analyses, such as a focal amplification in 10q23.1 (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Figure 3</xref></bold>; High resolution image at <ext-link l:rel="related" l:ref-type="uri" l:ref="https://figshare.com/authors/_/1365237" ext-link-type="uri" xlink:href="https://figshare.com/authors/_/1365237" hwp:id="ext-link-1">https://figshare.com/authors/_/1365237</ext-link>). sCNAphase identified regions that had undergone an LOH event, which can provide additional insight into the mutational history of a tumor sample. For example both the sCNAphase and SKY analyses of HCC1143 identified 4 copies of chromosome 5 (<bold>Supplementary Figure</bold> 2AB), however our analyses revealed that this chromosome as having undergone LOH. Our results indicate that this mutation was not the result of the duplication of both parental chromosomes but rather the deletion of one, coupled with the 4x amplification of the other.</p></sec><sec id="s5" hwp:id="sec-5"><title hwp:id="title-9">sCNAphase accurately calculates tumor ploidy, tumor purity and sCNAs across a range of different levels of simulated tumor purity</title><p hwp:id="p-22">The presence of stromal cells, or other cells with a normal diploid genome in a solid tumor sample can impact the capacity of genomic-based approaches to characterize mutations in a tumor sample (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-5" hwp:rel-id="ref-8">Carter et al. 2012)</xref>. To assess the performance of sCNAphase to characterize impure tumor samples, simulated mixtures from HCC1143 and HCC1954 (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">Wilks et al. 2014)</xref> as well as HCC1187 and HCC2218 from Illumina BaseSpace (<ext-link l:rel="related" l:ref-type="uri" l:ref="https://basespace.illumina.com" ext-link-type="uri" xlink:href="https://basespace.illumina.com" hwp:id="ext-link-2">https://basespace.illumina.com</ext-link>) were analyzed (see Methods). To simulate the range of tumor heterogeneities found in primary tumor samples, each cell-line had a number of mixtures analyzed, each with varying proportions of tumor cell-line DNA (95%, 80%, 60%, 40%, 20%, 10%, 5% and 0% - see methods). Each mixture and matched normal sample was passed through the sCNAphase pipeline. Given that the ploidy estimates from the pure cell lines were comparable to the results from SKY (<xref ref-type="table" rid="tbl3" hwp:id="xref-table-wrap-3-1" hwp:rel-id="T3"><bold>Table</bold> 3</xref>), we assessed the degree to which the analysis from the mixture samples were consistent with the results from the pure cell lines. A similar analysis was carried out using CLImAT (version 1.1), the BAF-based approach most capable of characterizing low purity samples, which allowed us to examine the increased power offered by the use of PHFs.</p><table-wrap id="tbl3" orientation="portrait" position="float" hwp:id="T3" hwp:rev-id="xref-table-wrap-3-1 xref-table-wrap-3-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2/TBL3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T3</object-id><object-id pub-id-type="publisher-id">tbl3</object-id><label>Table 3.</label><caption hwp:id="caption-6"><title hwp:id="title-10">The capacity of sCNAphase to detect the focal sCNAs in COSMIC</title></caption><graphic xlink:href="038828_tbl3" position="float" orientation="portrait" hwp:id="graphic-6"/></table-wrap><p hwp:id="p-23">This analysis revealed that sCNAphase was able to accurately recapitulate the ploidy results from each of the pure cell-lines across the majority of the mixtures as well as accurately determine the level of tumor DNA in each sample (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Figure 4AB</xref></bold>, <bold>Supplementary Table</bold> 2). The only inaccurate ploidy calls came from the mixtures that contained ultra-low levels of cell-line DNA (5%) in HCC1954 and HCC2218. Despite this, sCNAphase was still able to accurately report on the amount of cell-line DNA in these samples. Across the entire cohort of mixtures, the sCNAphase results only deviated from the simulated proportion by maximum 2% (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Figure 4B</xref></bold>, <bold>Supplementary Table</bold> 2). Furthermore, sCNAphase estimated that all 0% cell-line DNA mixtures contained less than 0.1% tumor content, an important measure of the robustness of the algorithm. Cellularity estimates, which can be calculated as a function of tumor purity and ploidy (see Methods) were also reported (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Figure 4C</xref></bold>). The sCNAs identified were consistent across the mixtures (see Methods) except for the 5% mixtures from HCC2218 and HCC1954 in which the ploidy estimates had been incorrectly calculated (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Figure 4D</xref></bold>). Adjusting the ploidy to the correct value rescued the segmentation and allowed sCNAphase to capture the same broad copy number profile from these 5% mixtures (<bold>Supplementary Figure</bold> 3).</p><fig id="fig4" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4 xref-fig-4-5 xref-fig-4-6 xref-fig-4-7 xref-fig-4-8 xref-fig-4-9 xref-fig-4-10"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Figure 4.</label><caption hwp:id="caption-7"><title hwp:id="title-11">Inference from sCNAphase and CLImAT on HCC1954 (hyper-tetraploid), HCC2218 (tetraploid), HCC1143 (hypo-tetraploid) and HCC1187 (hypo-triploid across a range of tumor purity.</title><p hwp:id="p-24">(A) Inferred ploidy as a function of tumor purity. (B) Estimated tumor purity as a function of simulated tumor purity (proportion of tumor DNA in sample). No results shown for CLImAT as it estimates cellularity only. (C) Estimated tumor cellularity (the proportion of tumor cells in each sample) as function of simulated purity. (D) self-consistency, measured as average of base-pair sensitivity and base-pair specificity, with 100% tumor sample estimate as tumor purity decreases.</p></caption><graphic xlink:href="038828_fig4" position="float" orientation="portrait" hwp:id="graphic-7"/></fig><p hwp:id="p-25">In comparison, CLImAT provided robust cellularity estimates for 3 of 4 samples down to 20% tumor purity, but substantially over-estimated tumor cellularity for low purity samples, including the 0% (i.e. normal) mixture sample (<xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-5" hwp:rel-id="F4">Figure 4C</xref>). The sCNA predictions of CLImAT were self-consistent down to 20% purity for 3 of 4 samples, although with lower self-consistency scores than sCNAphase (<xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-6" hwp:rel-id="F4">Figure 4D</xref>). However, CLImAT, only determined the correct ploidy for two of these cell-lines and for one of these cell-lines it was only in samples that contained high levels of cell-line DNA (HCC1143 at higher than 60%). CLImAT failed to recognize HCC2218 and HCC1954 as tetraploids across all levels of tumor purity (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-7" hwp:rel-id="F4">Figure 4B</xref></bold>). Furthermore, CLImAT reported inflated cellularity estimates in the low purity mixtures (CLImAT does not report purity). As a result, CLImAT estimated every mixture containing 0% tumor cell-line DNA, to contain a substantial proportion (i.e. greater than 40%) of tumor cells (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-8" hwp:rel-id="F4">Figure 4C</xref></bold>). This comparison highlights the difficulties involved in correctly predicting ploidy and accurately estimating tumor cellularity in low purity mixtures. These results showcase the utility of the increased power offered by PHFs to resolve complex tumor genomes over the current state-of-the-art BAF based approach.</p></sec><sec id="s6" hwp:id="sec-6"><title hwp:id="title-12">Microarray analysis of cell-lines validates the sCNAphase results</title><p hwp:id="p-26">The Cancer Cell Line Encyclopedia and the COSMIC Cell Line Project (<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">Forbes et al. 2015)</xref> provide an independent annotation of the mutations present in publically available cell-lines. The copy number profiles of the cell-lines analyzed by sCNAphase had been characterized as part of this COSMIC project, and were independently profiled using a PICNIC analysis of microarray data (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">Greenman et al. 2010)</xref>. This resource provides us with an independent annotation of the specific sCNAs in each of these celllines and allows us to investigate the capacity of sCNAphase to report on individual sCNAs. To compare the annotations of these cell-lines, the base ploidy for each cell-line needed to be determined. With the exception of HCC1187, all cell-lines were treated as tetraploids, while HCC1187 was considered as triploid. Any segment determined to have a value higher than this was defined as an amplification and those with a lower value were defined as a deletion. Sensitivity and specificity were calculated by counting the number of bases overlapping between two events which have the same direction (i.e. gain or loss) relative to the base ploidy (see Methods). This comparison revealed that the majority of events present in the COSMIC annotation of each cell line could be found across the range of mixtures for each cell-line using sCNAphase, when ploidy was properly assigned (<bold><xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Figure 5A, B</xref></bold>). In the samples in which ploidy was incorrectly calculated (5% HCC2218 and HCC1954), the capacity of sCNAphase to reflect the COSMIC results was greatly diminished. A similar comparison with the results from CLImAT showed that this approach failed to correctly profile any of the HCC2218 or HCC1954 mixtures (<bold><xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-2" hwp:rel-id="F5">Figure 5A, B</xref></bold>). The comparison of the sCNAs identified by an array-based approach to those identified by sCNAphase and CLImAT, illustrate the ability of sCNAphase to identify valid copy number changes across a range of different simulated tumor cellularities.</p><fig id="fig5" position="float" orientation="portrait" fig-type="figure" hwp:id="F5" hwp:rev-id="xref-fig-5-1 xref-fig-5-2 xref-fig-5-3 xref-fig-5-4 xref-fig-5-5 xref-fig-5-6"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;038828v2/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Figure 5.</label><caption hwp:id="caption-8"><title hwp:id="title-13">sCNAphase recapitulates the COSMIC annotation of these cell-lines across a range of purities.</title><p hwp:id="p-27">Consistency with COSMIC segmentation for copy number (A, B) and LOH (C,D) at varied tumor purity. For tumor samples at different tumor purity, the base-pair sensitivity in (A,C) and base-pair specificity in (B,D), was calculated by overlapping sCNAphase and CLImAT segmentations estimated at a particular tumor purity with COSMIC segmentations based on 100% purity tumor samples. Each of the four cell-lines was represented a particular point shape as indicated in the legend. Results from sCNAphase and CLImAT are shown in green and black respectively. The copy number segmentations of chr9 p-arm HCC1187 from COSMIC, sCNAphase and CLImAT were shown in (E) in blue, green and black hash lines respectively. BAFs at this region in (F) support the loss of heterozygosity in p-arm except for the region highlighted in the pink box (39M-47M). For most of this 8M region, sCNAphase did not report copy number or LOH due to the highly variable BAFs which give merging errors (see Method).</p></caption><graphic xlink:href="038828_fig5" position="float" orientation="portrait" hwp:id="graphic-8"/></fig><p hwp:id="p-28">LOH events are a common feature of the cancer genome and have been previously linked to the inactivation of tumor suppressors (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">Side et al. 1997</xref>; <xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">Tuna et al. 2009)</xref>. Given the capacity of our approach to quantify and identify the haplotype of each chromosome, we assessed the ability of sCNAphase to identify the LOH events present in the COSMIC annotation of these cell lines (<bold><xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-3" hwp:rel-id="F5">Figure 5C, D</xref></bold>). This comparison showed sCNAphase identified approximately 90% of the regions of LOHs in COSMIC annotations of these cell-lines while producing only few spurious results (except for HCC1954). Furthermore, sCNAphase was still able to identify the same regions of LOH in the ultra-low purity samples in which ploidy had been incorrectly assigned.</p><p hwp:id="p-29">Despite the high level of similarity between the results from sCNAphase and COSMIC for the majority of cell-lines, few regions of LOH in the COSMIC annotation of these cell-lines were not identified in the corresponding sCNAphase analysis. For example, chr9p1-13 of HCC1187 was defined as a region of LOH by both COSMIC and CLImAT (<bold><xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-4" hwp:rel-id="F5">Figure 5E</xref></bold>), however only small islands of LOH were identified in the sCNAphase analysis of the same region (marked in pink). To identify any shortcomings in the sCNAphase algorithm, we investigated the raw BAFs from this location. This analysis revealed that these regions are unlikely to be homozygous, as the individuals BAFs are highly variable, unlike the remainder of the chromosome (<bold><xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-5" hwp:rel-id="F5">Figure 5F</xref></bold>).</p><p hwp:id="p-30">In the analysis of HCC1954 there was a low degree of overlap between the regions of LOH identified by sCNAphase and CLImAT and those present in the COSMIC LOH annotation of the cell-line. Closer inspection indicated that these differences were due to large chromosomal regions predicted to be LOH in COSMIC, but which appear to be regions of high copy number and allelic imbalance, rather than regions of LOH (<bold>Supplementary Figure</bold> 4). We also found substantial differences between the copy number estimates from COSMIC and sCNAphase for multiple chromosomal arms for HCC1954 as well as differences between the ploidy estimates in COSMIC and those from sCNAphase and the previous SKY analyses (<bold>Supplementary Figure</bold> 2,4). Given the inconsistent results, the COSMIC annotation of the HCC1954 may underestimate the ploidy of this cell-line (<xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-3" hwp:rel-id="T2">Table 2</xref>), and as a result, may have reported some regions of LOHs and focal deletions for HCC1954 that do not reflect the true copy number profile of this cell-line.</p></sec><sec id="s7" hwp:id="sec-7"><title hwp:id="title-14">Focal sCNAs identified by sCNAphase mirror those identified by microarray analysis</title><p hwp:id="p-31">Given the clinical importance of recurrent focal amplifications in the cancer process, we assessed the performance of sCNAphase and CLImAT to detect the focal amplifications (100kb to 4Mb) present in the COSMIC annotation for these four cell-lines, using a 50% reciprocal overlap criterion (see Methods). In the analysis of the pure cell-lines sCNAphase was able to detect majority of the focal amplifications present in the COSMIC annotation of each of these cell-lines (see Methods), with a sensitivity approximately twice that of CLImAT, as well as a specificity which was as good or better than CLImAT (<xref ref-type="table" rid="tbl3" hwp:id="xref-table-wrap-3-2" hwp:rel-id="T3"><bold>Table</bold> 3</xref>, <bold>Supplementary Table</bold> 3). As the tumor purity decreased to 10%, the performance of sCNAphase remained unchanged. However the performance of CLImAT was unstable for all four celllines. At 10% tumor purity, CLImAT failed to identify any of the focal amplifications present in the COSMIC annotations from any of the cell-lines, while sCNAphase was able to identify over 60% of the focal mutations.</p><p hwp:id="p-32">The sCNAphase analysis of HCC1143 and HCC1187 was still able to identify the majority of focal events at 5% tumor purity, the sensitivity of sCNAphase dropped significantly for HCC1954 and HCC2218, however this was due to the underestimation of the tumor ploidy in these samples. Despite this, sCNAphase was able to detect at least 12 copies of the pathologically relevant <italic toggle="yes">ERBB2</italic> in HCC1954 and HCC2218 across the entire cohort of mixtures (<bold>Supplementary Table</bold> 4), highlighting the diagnostic potential of sCNAphase (<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">Neve et al. 2006</xref>; <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">Kao et al. 2009)</xref> at even 5% tumor DNA. Likewise, another focal peak of amplification, that was found to be recurrently altered in breast cancer (11q13) (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">Desnoyers et al. 2007</xref>; <xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">Sawey et al. 2011</xref>), was detected in both the 100% HCC1143 and HCC1954 samples, as well as their corresponding 5% mixtures. The identification of focal events, including those that are well known to be clinically significant, across the full range of mixtures demonstrates the capacity of sCNAphase to identify pathologically relevant sCNAs in ultra-low purity samples.</p><p hwp:id="p-33">Homozygous deletions are another class of copy number mutation involved in the tumorigenic process (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">Knudson et al. 1975</xref>; <xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">Cairns et al. 1995</xref>; <xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">Li et al. 1997)</xref>. The COSMIC annotations show that there are 7 homozygous deletions larger than 100Kb in these four cell-lines (<bold>Supplementary Table</bold> 5). sCNAphase was able to consistently detect the 3 longer homozygous deletions from HCC1143 and HCC1187. The size of a focal deletion, more specifically, the number of germ-lines SNPs in the region limits sCNAphase from identifying shorter events. Our analysis of HCC1954 did not detect the longer deletion from chr22 of HCC1954, however analysis of the raw sequencing data suggest that this deletion may be shorter than the 332kb listed in the COSMIC annotation, as the read depth at the flanking region is significantly higher than the deleted region (<bold>Supplementary Figure</bold> 5). Despite this, sCNAphase did not identify any false positives and was able to consistently identify these deletions at minimal levels of tumor purity. In contrast, CLImAT failed to identify any of homozygous deletions present in COSMIC, however it did classify a number of other areas, as homozygous deletions that were not present in either the COSMIC or sCNAphase results.</p></sec><sec id="s8" hwp:id="sec-8"><title hwp:id="title-15">sCNAphase identifies biologically significant events in samples too complex for existing methodologies</title><p hwp:id="p-34">The comparison between the results from the COSMIC microarray and the sCNAphase analysis of the same cell-lines, demonstrated the capacity of our approach to identify recurrent focal sCNAs that have been previously associated with cancer. While the detection of focal amplifications is essential for any tool designed to characterize the copy number profile of a tumor genome, we wanted to access the capacity of sCNAphase to identify potentially biologically significant changes outside of these more prominent regions and in samples thought to be too complex for other studies.</p><p hwp:id="p-35">The use of microarrays to survey the tumor genome, made it possible to quantify the number of chromosomes in tumor sample, while identifying instances of LOH. These studies identified regions recurrently altered by LOH but contained a normal karyotype, something that trait that thought to be the result of multiple mutational processes and too complex to be observed across the genome using prior methodologies. A number of these regions of recurrent Copy Neutral-LOH (CN-LOH) have been directly linked to cancer and include <italic toggle="yes">TP53</italic> as well as <italic toggle="yes">CDNK2A</italic>(<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">Murthy et al. 2002</xref>; <xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">Mullighan et al. 2007)</xref>. However the identification of these complex regions with microarrays was not always possible, as they are obscured in samples that contained small amounts of tumor content (&lt;40%) (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-6" hwp:rel-id="ref-8">Carter et al. 2012)</xref>. Examination of the results from the analysis of the pure cell-lines with sCNAphase, revealed a number of regions that had undergone LOH and contained two or more copies. Furthermore, a number of these regions were present in multiple cell-lines. To investigate the capacity of our tool to characterize this complex event, in samples too complex for existing methods, we examined the results from sCNAphase to identify instances of recurrent LOH in segments containing two or copies from samples containing very low levels of tumor DNA.</p><p hwp:id="p-36">Analysis of the mixtures that contained 10% tumor DNA, revealed that the majority of the regions of CN-LOH, or regions of Acquired Uniparental Polysomy (AUPP - LOH in regions that contain three or more copies), could be identified in the analysis of the corresponding pure cell-lines. Analysis of these low tumor content mixtures, revealed a number of regions of AUPP or CN-LOH shared across multiple cell-lines (<bold>Supplementary Table</bold> 6). These recurrent regions of LOH included chr5q and chr17p as well as parts of chr17q, all of which had been previously found to undergo recurrent CN-LOH in cancer (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-2" hwp:rel-id="ref-34">Murthy et al. 2002</xref>; <xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">Lips et al. 2007</xref>; <xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-2" hwp:rel-id="ref-48">Tuna et al. 2009</xref>; <xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">Pedersen et al. 2013)</xref>.</p><p hwp:id="p-37">One of these regions, the p arm of chromosome 17 was found to be altered in all of these cell-lines (this region was not classed as LOH in the 10% mixture from HCC1143, but was correctly classified in the 5% mixture), a result echoed in the literature, which describe the tumor suppressor <italic toggle="yes">TP53</italic>, a gene located in this region as the most common region of CN-LOH across a range of different types of cancer (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-3" hwp:rel-id="ref-48">Tuna et al. 2009</xref>; <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">Whibley et al. 2009)</xref>. To investigate the biological impact of these recurrent regions of LOH and the single nucleotide resolution offer by the HTS platform, we performed an in-depth examination of the <italic toggle="yes">TP53</italic> locus in each of these cell-lines. This analysis revealed homozygous somatic mutations in <italic toggle="yes">TP53</italic> for three of the cell-lines (<bold>Supplementary Figure</bold> 6). In the remaining cell-line HCC2218, two heterozygous germline SNPs were identified (<bold>Supplementary Table</bold> 7), one of which, R283C has been previously shown to increase a carrier’s risk of developing cancer (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-3" hwp:rel-id="ref-34">Murthy et al. 2002</xref>; <xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">Keller et al. 2004</xref>; <xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">Manoukian et al. 2007)</xref>. It is likely that the loss of the wild type allele and the amplification of the deleterious SNP only increases this risk. These results demonstrate the power offered by HTS and sCNAphase to characterize the biological impacts of a complex mutation in complex samples.</p></sec><sec id="s9" hwp:id="sec-9"><title hwp:id="title-16">Discussion</title><p hwp:id="p-38">Although somatic copy number alterations are a well-established driver of cancer, the capacity to identify these mutations are impacted by a number of issues including varying levels of tumor purity and frequent changes in tumor ploidy. As a result, the majority of methods designed to characterize the sCNAs in the cancer genome are unable to accurately profile a significant fraction of primary tumor samples. In this study, we have shown that by taking a haplotype-based approach, sCNAphase can overcome these issues and reliably characterize both genome-wide copy number changes and the individual mutations present in a tumor genome across a range of tumor purities.</p><p hwp:id="p-39">The results shown here confirm the capacity of sCNAphase to accurately reflect the copy number profile of a range of different primary tumor like samples. This was achieved by demonstrating that sCNAphase could precisely determine a number of key factors that are essential to correctly characterizing the full scope of copy number changes in a tumor sample. Comparison of the results from the sCNAphase to those from SKY and flow cytometry, illustrated the ability of sCNAphase to correctly reflect the genome-wide changes in ploidy (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Figure 3</xref></bold> and <bold>Supplementary Figure</bold> 2). Using a range of mixtures, to simulate the challenges posed by low-cellularity primary tumors, we were able to recapitulate the changes in ploidy seen in the analysis of the pure cell-lines, across the spectrum of tumor purities (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-9" hwp:rel-id="F4">Figure 4</xref></bold>). Equally important was that the sCNAphase analyzes of the mixtures that did not contain any cell-line DNA, did not produce false positive results (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-10" hwp:rel-id="F4">Figure 4</xref></bold>). When the specific copy number changes identified by sCNAphase were compared to those identified by microarray, it was apparent that our methodology was able to accurately reflect the individual sCNAs present, across the majority of samples (<bold><xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-6" hwp:rel-id="F5">Figure 5</xref></bold>). In depth examination of the results from sCNAphase revealed a number of changes that could be linked to the tumorigenic process in these cell-lines, highlighting the potential of this tool to identify biologically significant changes in primary tumor samples. Furthermore, when compared to CLImAT, a BAF-based tool that was found to best handle the challenges posed by primary tumors (<xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-3" hwp:rel-id="T1"><bold>Table</bold> 1</xref>), sCNAphase was found to consistently outperform this methodology, highlighting the potential offered by our PHF-based approach. Together, these results demonstrate that using PHFs, sCNAphase is able to better reflect the full range of copy number changes in samples representative of the complexity present in primary tumors.</p><p hwp:id="p-40">The accurate characterization of the copy number profile in low cellularity samples as well as the identification of mutations in cancer genes, is suggestive of the potential clinical utility of this tool. While the additional testing with a larger cohort of primary tumor samples is needed to fully realize this, our PHF based approach provides a method to identify the sCNAs in samples from which other tools cannot identify any sCNAs. In addition to low purity tumors or cancer types that routinely suffer from contaminating cells, a potential application of our PHF-based methodology would be in studies that aim to profile the copy number changes in a tumor through the analysis of circulating tumor DNA. Circulating tumor DNA, has been previously shown to contain mutations present in the tumor genome, but tumor DNA in circulation is mixed with DNA from normal cells and the tumor purity is frequently low (10% at most) (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">Newman et al. 2014)</xref>. While sCNAphase can successfully profile low purity mixtures, it is likely that in order to realize this an optimized version of the tool will need to be developed.</p><p hwp:id="p-41">In conclusion, we have provided evidence to show that sCNAphase is a robust software package, capable of characterizing the copy number profile of cancer samples, across a range of different of levels of tumor purity. We have shown that sCNAphase is able to correct for the presence of contaminating normal cells in tumor samples to confidently estimate the genome-wide sCNA changes as well as accurately identify the presence of individual sCNAs. Comparison of the results from sCNAphase to those generated using BAF, shows the dramatic increase in power to resolve these complex genomes offered by our PHF focused approach. In addition, this tool provides an effective way of visualizing data and identifies regions that have undergone a LOH event. Together, these results highlight the strength of sCNAphase and showcase its potential to identify biologically significant changes in a clinical setting.</p></sec><sec id="s10" hwp:id="sec-10"><title hwp:id="title-17">Methods</title><sec id="s10a" hwp:id="sec-11"><title hwp:id="title-18">Datasets</title><p hwp:id="p-42">The Illumina whole genome sequencing data of cell-lines, HCC1143, HCC1954, HCC1143BL, HCC1954BL were collected from Variant Calling Benchmark 4 provided by The Cancer Genome Atlas (TCGA) (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-2" hwp:rel-id="ref-50">Wilks et al. 2014)</xref>, and HCC1187, HCC1187BL, HCC2218 and HCC2218BL were from Illumina BaseSpace. The tumor cell-lines, HCC1143, HCC1954, HCC1187 and HCC2218 were cultured from breast ductal tissue, sequenced at 50x, 58x, 93x and 83x. Patient-matched normal samples, HCC1143BL, HCC1954BL, HCC1187BL and HCC2218BL were from peripheral blood, sequenced at 60x, 71x, 49x and 37x.</p><p hwp:id="p-43">The Variant Calling Benchmark 4 simulated tumor-normal mixture samples of HCC1143/HCC1143BL, HCC1954/HCC1954BL were at 30x coverage. They were created by mixing 5%, 20%, 40%, 60%, 80% and 95% of normal DNA to tumor DNA. The normal cell-lines HCC1143BL.30x.compare, HCC1954BL.30x.compare, were sequenced independently at 30x, different from the normal samples used to create the mixture samples. Because BaseSpace provides no mixtures samples for HCC1187/HCC1187BL, HCC2218/HCC2218BL, we created the mixture samples at 30x coverage with 5%, 20%, 40%, 60%, 80% and 95% of tumor DNA, by randomly sampling and mixing suitable amount of reads from tumor and normal samples. To create the low coverage normal controls, we down-sampled bam files of the HCC1187BL and HCC2218BL to 30x coverage. Therefore, for each tumor/normal pairs, there are 6 mixture samples, and 1 independent normal control. In the same way, we created 10% tumor- normal mixtures for all four cell-lines in order to assess the capacity of sCNAphase at very low level tumor DNA samples.</p><p hwp:id="p-44">All the tumor cell-lines are from high-grade breast ductal carcinoma. Based on the expression patterns, HCC1143, HCC1954 and HCC1187 were classified as the Basal A subtype, and HCC2218 as the Luminal subtype. HCC1954 and HCC2218 showed over-expression of <italic toggle="yes">ERBB2</italic>(<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-2" hwp:rel-id="ref-35">Neve et al. 2006</xref>; <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-2" hwp:rel-id="ref-23">Kao et al. 2009)</xref>.</p></sec><sec id="s10b" hwp:id="sec-12"><title hwp:id="title-19">Workflow</title><p hwp:id="p-45">The workflow is described in <bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Figure 2</xref></bold>. The workflow includes the determination of the BAF for each heterozygous SNP (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Figure 2a</xref></bold>), generation of phased allelic depths (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Figure 2b</xref></bold>), estimation of sCNAs as well as tumor purity and tumor ploidy (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-6" hwp:rel-id="F2">Figure 2c</xref></bold>). In order to generate allelic phase information, the pipe-line relies on external software for SNP calling, haplotype phasing in the pre-processing steps. Specifically, in current analysis, we start by calling SNP variants from pre-mapped Illumina pair-end sequencing data using BCFtools (Li et al. 2009) in VCF format. Then we used SHAPEIT2 (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-4" hwp:rel-id="ref-15">Delaneau et al. 2013)</xref> to perform population-based haplotype phasing at the SNP variants. Notably, the variant calling and in-silico haplotype phasing are only performed once on a normal sample rather than all tumor samples. This is because population-based haplotype phasing is based on a set of common germ-line SNPs and INDELs; however tumor genome is usually significantly altered, therefore not suitable for calling and phasing SNP variants. For the tumor samples, rather than calling variants, we calculated the allelic depths on the same set of SNP variants using BCFtools.</p><p hwp:id="p-46">Due to somatic mutations in tumor, the alleles in tumor are occasionally different from those in normal. The estimation process first checks the consistency of an alternative allele in normal and tumor samples, and then filters loci with inconsistent alternative alleles. After that, sCNAphase merges phased ADs every <italic toggle="yes">n</italic> loci. This step significantly reduces the variability of the allelic frequencies, and therefore increase the power in calling sCNAs.</p><p hwp:id="p-47">To determine the tumor ploidy, the next step is searching through all possible values from 2 to 5, incrementing by 0.2. Given an assumed tumor ploidy, the pipe-line identifies the tumor cellularity and copy number profile, which is most fitted to the merged read depths and phased allelic depths. As such, the estimated copy number profile with the maximal likelihood is chosen with the corresponding tumor ploidy, cellularity estimations. Based on this estimation, the pipe-line can generate varied outputs including a) a copy number segmentation file indicating which regions are amplified; b) a vcf file includes the genotypes, allelic copy numbers and phases for the SNPs; c) the dSKY plots which resembles the Spectral KaryotYping (SKY) plots. sCNAphase is powered by multithread techniques. This ploidy estimation step take approximately 4 hours on a machine with 12 CPUs at 1600MHz.</p></sec><sec id="s10c" hwp:id="sec-13"><title hwp:id="title-20">Calculating the parental allele frequency</title><p hwp:id="p-48">Given the allelic phase calculated from SHAPEIT2, the two alleles at each SNP are arranged into two haplotypes for the parental chromosomes. If one haplotype is randomly chosen as maternal, the fraction of maternal allele depth <italic toggle="yes">m<sub>i</sub></italic> over read depth <italic toggle="yes">d<sub>i</sub></italic> at each SNP reflects the amplification of the amplification of one parental chromosome over the other. Defined for a regional n consecutive SNPs, the <italic toggle="yes">parental haplotype frequency</italic>(PHF) is the sum of maternal allele depth mi to the sum of read depth di as follows:</p><disp-formula id="eqn1" hwp:id="disp-formula-1"><alternatives hwp:id="alternatives-1"><graphic xlink:href="038828_eqn1.gif" position="float" orientation="portrait" hwp:id="graphic-9"/></alternatives></disp-formula><p hwp:id="p-49">A PHF of 0 or 1 corresponds to a homozygote. For a maternally amplified region, the PHF is expected to be above 0.5. B-allelic frequency (BAF) defined as the fraction of the alternative allelic depth in this region, however, would vary a lot about 0.5, because the amplified allele can be either the reference or alternative allele. In this paper, the number consecutive SNPs (<italic toggle="yes">n</italic>) in a region was set to be 40, but it can be other values.</p><p hwp:id="p-50">In ideal cases, when there are no allele-specific biases, such as allelic-specific enrichment during PCR, the probability of seeing maternal allelic depth <italic toggle="yes">m<sub>i</sub></italic>, given the genotypes <italic toggle="yes">g</italic><sub>i</sub><sup>(t)</sup>, read depth <italic toggle="yes">d</italic><sub>i</sub><sup>(t)</sup>, satisfy a binomial distribution of from a tumor sample is dependent on the genotypes <italic toggle="yes">g</italic><sub>i</sub><sup>t</sup> read depth <italic toggle="yes">d</italic><sub>i</sub><sup>(t)</sup>, which approximates a binomial distribution of:
<disp-formula id="eqn2" hwp:id="disp-formula-2" hwp:rev-id="xref-disp-formula-2-1 xref-disp-formula-2-2 xref-disp-formula-2-3 xref-disp-formula-2-4"><alternatives hwp:id="alternatives-2"><graphic xlink:href="038828_eqn2.gif" position="float" orientation="portrait" hwp:id="graphic-10"/></alternatives></disp-formula>
<disp-formula id="eqn3" hwp:id="disp-formula-3"><alternatives hwp:id="alternatives-3"><graphic xlink:href="038828_eqn3.gif" position="float" orientation="portrait" hwp:id="graphic-11"/></alternatives></disp-formula>
in which the superscript, t differentiates a tumor sample from the matched normal. <italic toggle="yes">x</italic><sub>i</sub><sup>(t)</sup> and <italic toggle="yes">y</italic><sub>i</sub><sup>(t)</sup> are copy numbers of the maternal and paternal alleles for SNP i, which define the genotype <italic toggle="yes">g</italic><sub>i</sub><sup>(t)</sup>. Therefore given a genotype of {MMP, Pi is 2/3. Different from absolute copy numbers, <italic toggle="yes">x</italic><sub>i</sub><sup>(t)</sup> and <italic toggle="yes">y</italic><sub>i</sub><sup>(t)</sup> are copy numbers relative to the germ-line allelic copy number. Therefore if the copy number for the germ-line maternal allele is <italic toggle="yes">x</italic><sub>i</sub><sup>(n)</sup>, the absolute maternal allelic copy number in tumor would be <italic toggle="yes">x</italic><sub>i</sub><sup>(n)</sup> <italic toggle="yes">x</italic><sub>i</sub><sup>(t)</sup>. <italic toggle="yes">x</italic><sub>i</sub><sup>(t)</sup> of 1 means no somatic copy number alterations. In most cases, <italic toggle="yes">x</italic><sub>i</sub><sup>(n)</sup> and <italic toggle="yes">y</italic><sub>i</sub><sup>(n)</sup> are both 1 given the normal being the diploid genome, so that <italic toggle="yes">x</italic><sub>i</sub><sup>(t)</sup> represents the absolute copy number.</p><p hwp:id="p-51">When the genotype for a tumor sample is unknown at a site <italic toggle="yes">i</italic>, the parental allelic frequency, <italic toggle="yes">PHF<sub>i</sub><sup>(i)</sup></italic> is the unbiased estimation of <italic toggle="yes">P</italic><sub>i</sub><sup>(t)</sup>. The variance of <italic toggle="yes">PHF</italic><sub>i</sub><sup>(t)</sup> from <italic toggle="yes">P</italic><sub>i</sub><sup>(t)</sup> is,</p><disp-formula id="eqn4" hwp:id="disp-formula-4"><alternatives hwp:id="alternatives-4"><graphic xlink:href="038828_eqn4.gif" position="float" orientation="portrait" hwp:id="graphic-12"/></alternatives></disp-formula><p hwp:id="p-52">Therefore, as the read depth <italic toggle="yes">d</italic><sub>i</sub><sup>(t)</sup> increases, the variance becomes smaller so that the allelic amplification can be inferred from the average <italic toggle="yes">PHF<sub>i</sub></italic>. For the genotype of {MMP} (<italic toggle="yes">P</italic><sub>i</sub><sup>(t)</sup> = 2/3) and 30x sequencing coverage, the <italic toggle="yes">PHF</italic><sub>i</sub><sup>(t)</sup> varies in the range of 2/3 ± 0.086, in 68% of cases (Wald method). This spans possible allelic copy number ratios of 3/5, 2/3, 4/5. For this maternally amplified sCNAs, the merging on the allelic depths at neighbor SNPs, would increase the depth, therefore reduce the variability. If adding up the depths at every 40 SNPs, the variance reduces to 0.023 in 90% cases. In this case, genotypes other than {MMP} become very unlikely.</p></sec><sec id="s10d" hwp:id="sec-14"><title hwp:id="title-21">Normal-tumor paired test</title><p hwp:id="p-53">Due to germ-line copy number variations (CNVs), the genotypes of a normal sample cannot be assumed as {MP} for all the SNPs, although for most of them the assumption is fitted. In order to call sCNAs (copy number gain or loss from the germ-line copy numbers), both the tumor and paired normal samples are required.</p><p hwp:id="p-54">Assuming there are no somatic alterations, the <italic toggle="yes">p</italic><sub>i</sub> in <xref ref-type="disp-formula" rid="eqn2" hwp:id="xref-disp-formula-2-1" hwp:rel-id="disp-formula-2">Equation <bold>2</bold></xref> can be approximated by the <italic toggle="yes">PHF</italic><sub>i</sub><sup>(n)</sup> from the matched normal sample at a locus <italic toggle="yes">i</italic>,
<disp-formula id="eqn5" hwp:id="disp-formula-5" hwp:rev-id="xref-disp-formula-5-1"><alternatives hwp:id="alternatives-5"><graphic xlink:href="038828_eqn5.gif" position="float" orientation="portrait" hwp:id="graphic-13"/></alternatives></disp-formula>
in which <italic toggle="yes">m</italic><sub>i</sub><sup>(n)</sup> and <italic toggle="yes">d</italic><sub>i</sub><sup>(n)</sup> correspond to the maternal allelic depth and read depth for a SNP from the paired normal sample.</p><p hwp:id="p-55">The fitness of this assumption can be analyzed visually from Q-Q plot, which is commonly used to compare if observations (an empirical distribution) fit into certain assumptions (an expected distribution). For a fitted assumption, the Q-Q plot is expected to be approximately y=x. In our case, this includes 1) calculate the probability at each SNP with <xref ref-type="disp-formula" rid="eqn2" hwp:id="xref-disp-formula-2-2" hwp:rel-id="disp-formula-2">Equation <bold>2</bold></xref>, <xref ref-type="disp-formula" rid="eqn5" hwp:id="xref-disp-formula-5-1" hwp:rel-id="disp-formula-5"><bold>5</bold></xref>; <xref ref-type="disp-formula" rid="eqn2" hwp:id="xref-disp-formula-2-3" hwp:rel-id="disp-formula-2">2</xref>) rank and treat each probability as the <italic toggle="yes">i</italic>th quantile. Since an <italic toggle="yes">PHFP</italic><sub>i</sub><sup>(n)</sup> varies about the <italic toggle="yes">p<sub>i</sub></italic>, this variation makes the expected distribution more variable than the empirical distribution of the observations. The Q-Q plot will be slightly deflated from y=x, even if there are no sCNAs in tumor sample. By merging the allelic depths in each haplotype, the increased depths will reduce the variance of <italic toggle="yes">PHF<sub>i</sub><sup>(n)</sup></italic> about the <italic toggle="yes">p</italic><sub>i</sub> which restores the Q-Q plot to y=x as shown in <bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Figure 1d.</xref></bold> The test on the merged phased ADs is sensitive enough to detect as low as 5% tumor DNA providing a normal-tumor mixture.</p></sec><sec id="s10e" hwp:id="sec-15"><title hwp:id="title-22">Hidden Markov Model on Allelic Depth and Read Depth</title><p hwp:id="p-56">For tumor-normal mixture samples with a tumor cellularity <italic toggle="yes">tc</italic>, the likelihood for observing the depths {<italic toggle="yes">m</italic><sub>i</sub><sup>(t)</sup>, <italic toggle="yes">d</italic><sub>i</sub><sup>(t)</sup>, <italic toggle="yes">W</italic><sub>i</sub><sup>(n)</sup>, <italic toggle="yes">d</italic><sub>i</sub><sup>(n)</sup>} still satisfy a binomial distribution in <xref ref-type="disp-formula" rid="eqn2" hwp:id="xref-disp-formula-2-4" hwp:rel-id="disp-formula-2">Equation <bold>2.</bold></xref> The <italic toggle="yes">P</italic><sub>i</sub><sup>(t)</sup>, in this case, is given as,
<disp-formula id="eqn6" hwp:id="disp-formula-6"><alternatives hwp:id="alternatives-6"><graphic xlink:href="038828_eqn6.gif" position="float" orientation="portrait" hwp:id="graphic-14"/></alternatives></disp-formula>
<disp-formula id="eqn7" hwp:id="disp-formula-7"><alternatives hwp:id="alternatives-7"><graphic xlink:href="038828_eqn7.gif" position="float" orientation="portrait" hwp:id="graphic-15"/></alternatives></disp-formula>
in which <italic toggle="yes">x<sub>i</sub><sup>(t)</sup></italic> and <italic toggle="yes">y<sub>i</sub><sup>(t)</sup></italic> are the maternal and paternal allelic copy numbers for a genotype <italic toggle="yes">g<sub>i</sub><sup>(t)</sup></italic></p><p hwp:id="p-57">Given the sum of read depths across all sites <italic toggle="yes">R</italic><sup>(n)</sup> and <italic toggle="yes">R</italic><sup>(t)</sup> for normal and tumor samples, the likelihood function of read depths <italic toggle="yes">d<sub>i</sub><sup>n</sup></italic> and <italic toggle="yes">d<sub>i</sub><sup>n</sup></italic> is
<disp-formula id="eqn8" hwp:id="disp-formula-8"><alternatives hwp:id="alternatives-8"><graphic xlink:href="038828_eqn8.gif" position="float" orientation="portrait" hwp:id="graphic-16"/></alternatives></disp-formula>
<disp-formula id="eqn9" hwp:id="disp-formula-9" hwp:rev-id="xref-disp-formula-9-1"><alternatives hwp:id="alternatives-9"><graphic xlink:href="038828_eqn9.gif" position="float" orientation="portrait" hwp:id="graphic-17"/></alternatives></disp-formula>
in which <italic toggle="yes">γ<sub>i</sub></italic> is a factor for the position specific biases, such as the mappability and GC-bias. This is expected to be comparable for tumor and normal samples, given the identical procedure of library preparation and sequencing platform. <italic toggle="yes">cn</italic><sub>i</sub><sup>(a)</sup> is the absolute copy number in tumor for SNP <italic toggle="yes">i</italic>. <italic toggle="yes">Σ<sub>j</sub>γ<sub>j</sub>cn<sub>j</sub></italic><sup>(a)</sup> and <italic toggle="yes">Σ<sub>j</sub>γ<sub>j</sub>cn<sub>j</sub></italic><sup>(n)</sup> only vary with global setting of copy numbers at each locus <italic toggle="yes">cn</italic><sub>j</sub><sup>(a)</sup>.</p><p hwp:id="p-58">The difference of the values for the tumor and normal samples reflects the ploidy change C from diploid, that is</p><disp-formula id="eqn10" hwp:id="disp-formula-10" hwp:rev-id="xref-disp-formula-10-1 xref-disp-formula-10-2"><alternatives hwp:id="alternatives-10"><graphic xlink:href="038828_eqn10.gif" position="float" orientation="portrait" hwp:id="graphic-18"/></alternatives></disp-formula><p hwp:id="p-59">Given the haploid coverage of normal and tumor samples at <italic toggle="yes">hc<sup>(n)</sup></italic> and <italic toggle="yes">hc<sup>(t)</sup></italic>, the expected read depth <italic toggle="yes">d</italic><sub>i</sub><sup>(t)</sup>, <italic toggle="yes">d</italic><sub>i</sub><sup>(n)</sup> can be calculated as follows,</p><disp-formula id="eqn11" hwp:id="disp-formula-11" hwp:rev-id="xref-disp-formula-11-1"><alternatives hwp:id="alternatives-11"><graphic xlink:href="038828_eqn11.gif" position="float" orientation="portrait" hwp:id="graphic-19"/></alternatives></disp-formula><disp-formula id="eqn12" hwp:id="disp-formula-12" hwp:rev-id="xref-disp-formula-12-1"><alternatives hwp:id="alternatives-12"><graphic xlink:href="038828_eqn12.gif" position="float" orientation="portrait" hwp:id="graphic-20"/></alternatives></disp-formula><p hwp:id="p-60">To find the somatic copy number alterations to the germ-line copy number, we define the relative copy number <italic toggle="yes">cn</italic><sub>i</sub><sup>(t)</sup> in tumor to the germ-line copy number <italic toggle="yes">cn</italic><sub>i</sub><sup>(n)</sup> in normal as,</p><disp-formula id="eqn13" hwp:id="disp-formula-13" hwp:rev-id="xref-disp-formula-13-1"><alternatives hwp:id="alternatives-13"><graphic xlink:href="038828_eqn13.gif" position="float" orientation="portrait" hwp:id="graphic-21"/></alternatives></disp-formula><p hwp:id="p-61">With <xref ref-type="disp-formula" rid="eqn9" hwp:id="xref-disp-formula-9-1" hwp:rel-id="disp-formula-9">Equation <bold>9</bold></xref>, <xref ref-type="disp-formula" rid="eqn10" hwp:id="xref-disp-formula-10-1" hwp:rel-id="disp-formula-10"><bold>10</bold></xref>, <xref ref-type="disp-formula" rid="eqn11" hwp:id="xref-disp-formula-11-1" hwp:rel-id="disp-formula-11"><bold>11</bold></xref>, <xref ref-type="disp-formula" rid="eqn12" hwp:id="xref-disp-formula-12-1" hwp:rel-id="disp-formula-12"><bold>12</bold></xref>, <xref ref-type="disp-formula" rid="eqn13" hwp:id="xref-disp-formula-13-1" hwp:rel-id="disp-formula-13"><bold>13</bold></xref>, <xref ref-type="disp-formula" rid="eqn10" hwp:id="xref-disp-formula-10-2" hwp:rel-id="disp-formula-10">Equation <bold>10</bold></xref> can be solved as,
<disp-formula id="eqn14" hwp:id="disp-formula-14" hwp:rev-id="xref-disp-formula-14-1 xref-disp-formula-14-2"><alternatives hwp:id="alternatives-14"><graphic xlink:href="038828_eqn14.gif" position="float" orientation="portrait" hwp:id="graphic-22"/></alternatives></disp-formula>
in which <italic toggle="yes">cn</italic><sub>i</sub><sup>(t)</sup> is the sum of <italic toggle="yes">x</italic><sub>i</sub><sup>(t)</sup> and <italic toggle="yes">y</italic><sub>i</sub><sup>(t)</sup> given the genotype <italic toggle="yes">g</italic><sub>i</sub><sup>(t)</sup>. Notably, the mappability factor is cancelled out in this equation. In <xref ref-type="disp-formula" rid="eqn14" hwp:id="xref-disp-formula-14-1" hwp:rel-id="disp-formula-14">Equation <bold>14</bold>,</xref> tumor cellularity <italic toggle="yes">tc</italic> and degree of ploidy alteration <italic toggle="yes">C</italic> are model parameters.</p><p hwp:id="p-62">With likelihood functions <italic toggle="yes">e</italic><sub>i</sub><sup>RD</sup> and <italic toggle="yes">e</italic><sub>i</sub><sup>AD</sup>, the complete likelihood of the Hidden Markov Model defined on read depth <italic toggle="yes">{<italic toggle="yes">RD</italic><sub>i</sub>}</italic> and allelic depth <italic toggle="yes">{<italic toggle="yes">AD</italic><sub>i</sub>}</italic> can be formulated as,
<disp-formula id="eqn15" hwp:id="disp-formula-15"><alternatives hwp:id="alternatives-15"><graphic xlink:href="038828_eqn15.gif" position="float" orientation="portrait" hwp:id="graphic-23"/></alternatives></disp-formula>
in which <italic toggle="yes">G</italic> stands for a set of <italic toggle="yes">n</italic> possible genotypes. The probability of genotype transition from a genotype <italic toggle="yes">g</italic><sub>i</sub> at SNP <italic toggle="yes">i</italic> to <italic toggle="yes">g<sub>i+i</sub></italic> at SNP <italic toggle="yes">j</italic> forms a fully connected transition matrix {<italic toggle="yes">t<sub>ij</sub></italic>}. <italic toggle="yes">Φ(g<sub>1</sub>)</italic> stands for the initial probability vector for the genotypes in G. The transition matrix is estimated using Baum-Welch; tumor cellularity <italic toggle="yes">tc</italic> is calculated from maximum likelihood estimation.</p></sec><sec id="s10f" hwp:id="sec-16"><title hwp:id="title-23">Determination of tumor purity and cellularity</title><p hwp:id="p-63">The percentage of tumor cells, <italic toggle="yes">tc</italic>, in a mixture sample is different from the percentage of the tumor DNA content in sequencing data <italic toggle="yes">tc<sub>d</sub></italic>. For tumor with higher than 2 ploidy, <italic toggle="yes">tc<sub>d</sub></italic> is bigger than <italic toggle="yes">tc</italic>. The relationship of the two scales is shown in following equation,
<disp-formula id="eqn16" hwp:id="disp-formula-16" hwp:rev-id="xref-disp-formula-16-1"><alternatives hwp:id="alternatives-16"><graphic xlink:href="038828_eqn16.gif" position="float" orientation="portrait" hwp:id="graphic-24"/></alternatives></disp-formula>
in which <italic toggle="yes">base</italic><sup>(n)</sup> and <italic toggle="yes">base</italic><sup>(t)</sup> are the haploid read depth for normal and tumor samples respectively. The relation between the expected read depths <inline-formula hwp:id="inline-formula-1"><alternatives hwp:id="alternatives-17"><inline-graphic xlink:href="038828_inline1.gif" hwp:id="inline-graphic-1"/></alternatives></inline-formula> and <inline-formula hwp:id="inline-formula-2"><alternatives hwp:id="alternatives-18"><inline-graphic xlink:href="038828_inline2.gif" hwp:id="inline-graphic-2"/></alternatives></inline-formula> at a SNP <italic toggle="yes">i</italic> and base level read depths <italic toggle="yes">base</italic><sup>(n)</sup> and <italic toggle="yes">base</italic><sup>(t)</sup> is,</p><disp-formula id="eqn17" hwp:id="disp-formula-17" hwp:rev-id="xref-disp-formula-17-1"><alternatives hwp:id="alternatives-19"><graphic xlink:href="038828_eqn17.gif" position="float" orientation="portrait" hwp:id="graphic-25"/></alternatives></disp-formula><disp-formula id="eqn18" hwp:id="disp-formula-18" hwp:rev-id="xref-disp-formula-18-1"><alternatives hwp:id="alternatives-20"><graphic xlink:href="038828_eqn18.gif" position="float" orientation="portrait" hwp:id="graphic-26"/></alternatives></disp-formula><p hwp:id="p-64">Assume <italic toggle="yes">d</italic><sub>i</sub><sup>n</sup> and <italic toggle="yes">d</italic><sub>i</sub><sup>t</sup> is close enough to <inline-formula hwp:id="inline-formula-3"><alternatives hwp:id="alternatives-21"><inline-graphic xlink:href="038828_inline3.gif" hwp:id="inline-graphic-3"/></alternatives></inline-formula> and <inline-formula hwp:id="inline-formula-4"><alternatives hwp:id="alternatives-22"><inline-graphic xlink:href="038828_inline4.gif" hwp:id="inline-graphic-4"/></alternatives></inline-formula>, the <italic toggle="yes">tc<sub>d</sub></italic> and <italic toggle="yes">tc</italic> can be calculated with <xref ref-type="disp-formula" rid="eqn16" hwp:id="xref-disp-formula-16-1" hwp:rel-id="disp-formula-16">equation <bold>16</bold></xref>, <xref ref-type="disp-formula" rid="eqn17" hwp:id="xref-disp-formula-17-1" hwp:rel-id="disp-formula-17"><bold>17</bold></xref> and <xref ref-type="disp-formula" rid="eqn18" hwp:id="xref-disp-formula-18-1" hwp:rel-id="disp-formula-18"><bold>18</bold></xref> as,</p><disp-formula id="eqn19" hwp:id="disp-formula-19"><alternatives hwp:id="alternatives-23"><graphic xlink:href="038828_eqn19.gif" position="float" orientation="portrait" hwp:id="graphic-27"/></alternatives></disp-formula></sec><sec id="s10g" hwp:id="sec-17"><title hwp:id="title-24">Estimation of tumor aneuploidy</title><p hwp:id="p-65">Predicting the average ploidy of tumor genome is a tricky problem, because the amount of DNA from a single cell in the primary tumor sample is unquantified for NGS. This causes ambiguity in ploidy estimation. A duplicated genome ({MMPP}) with 2 copies of chromosomes from each parent is indistinguishable from a diploid genome ({MP}), since the genotype of {MMPP} at ploidy of 4 and {MP} at ploidy of 2 are equivalent states and the allelic depths and read depths could not tell which is more likely. If there is a region with odd copy numbers, e.g. the genotype of {MMP} for a genome at average ploidy of 4, the region will strongly against the average ploidy of 2, as there is no equivalent genotype at that ploidy with 1.5 copies.</p><p hwp:id="p-66">sCNAphase searched through all possible average ploidy values (the parameter C in <xref ref-type="disp-formula" rid="eqn14" hwp:id="xref-disp-formula-14-2" hwp:rel-id="disp-formula-14">Equation 14</xref>) from 1.8 to 5.0 and choose the one with the maximal likelihood. sCNAphase was coupled with weak preferences for diploid, unless the allelic depths and read depths at some regions are easier to reconcile at higher copy numbers in higher ploidy. These regions are the “ploidy supporting region”.</p><p hwp:id="p-67">For example, <bold>Supplementary Figure 7</bold>a shows the maximum likelihood calculated for the ploidy of 1.9 to 5 for 100% tumor purity sample. Clearly, HCC2218 is more likely to be a tetraploid than a diploid, as chr3p had a region with 3 copy, which supports for higher ploidy (in <bold>Supplementary Figure 7</bold>c). However at 5% tumor purity, the average ploidy was predicted to be close to 2 (in <bold>Supplementary Figure 7ab)</bold>, as the less preferred copy number 2 to 3 at 0-50M region in chr3p did not generate as strong signal.</p></sec><sec id="s10h" hwp:id="sec-18"><title hwp:id="title-25">Adjustment for allelic mappability</title><p hwp:id="p-68">Mappability difference between reference and alternative allele produces a tiny bias on allelic depths. In a particular segment, if the maternal alleles are mostly reference alleles or alternative alleles, this bias on allelic mappability is amplified when merging successive maternal alleles. To adjust the allelic depths, we measured the bias by likelihood ratio. This is calculated by the likelihood of observing allelic depth of <italic toggle="yes">a<sub>i</sub></italic> and <italic toggle="yes">b<sub>i</sub></italic> at a site <italic toggle="yes">i</italic> with a reference nucleotide A, and an alternative nucleotide B. This can be formulated as,
<disp-formula id="eqn20" hwp:id="disp-formula-20"><alternatives hwp:id="alternatives-24"><graphic xlink:href="038828_eqn20.gif" position="float" orientation="portrait" hwp:id="graphic-28"/></alternatives></disp-formula>
<disp-formula id="eqn21" hwp:id="disp-formula-21"><alternatives hwp:id="alternatives-25"><graphic xlink:href="038828_eqn21.gif" position="float" orientation="portrait" hwp:id="graphic-29"/></alternatives></disp-formula>
in which A and B belongs to a set of {A,T,G,C}. A 2D matrix calculated from HCC1143 and HCC1954 is shown as follow in. Therefore allelic depths are recalibrated by increasing the count of an alternative allele by a factor of the bias.</p></sec><sec id="s10i" hwp:id="sec-19"><title hwp:id="title-26">Removal of merging errors at the boundary of adjacent sCNAs</title><p hwp:id="p-69">The PHFs are created by merging the phased allelic depths for every n loci, assuming the <italic toggle="yes">n</italic> loci are in the same copy number states. However, the merging errors occurs at a region which spans the boundary of two adjacent sCNAs, e.g. one at 5 copies and the other one at 1 copy. The PHFs will instead imply this region at 3 copies. To remove these merging error at the boundary of adjacent sCNAs, we performed an likelihood ratio test, as follows:</p><disp-formula id="eqn22" hwp:id="disp-formula-22"><alternatives hwp:id="alternatives-26"><graphic xlink:href="038828_eqn22.gif" position="float" orientation="portrait" hwp:id="graphic-30"/></alternatives></disp-formula><p hwp:id="p-70">The numerator assumes the <italic toggle="yes">n</italic> loci are in a single sCNAs, with a single genotype <italic toggle="yes">g</italic><sub>i</sub><sup>(t)</sup> from <italic toggle="yes">G</italic> which maximizes the likelihood. The numerator assumes the loci are from different sCNAs; therefore they can have an individual genotype, the <italic toggle="yes">g</italic><sub>i</sub><sup>(t)</sup> is chosen if it maximizes the likelihood. After the <italic toggle="yes">tc</italic> is estimated, sCNAphase performs this likelihood test for each PHF, before removes 1% of the PHF that failed this likelihood ratio test.</p></sec><sec id="s10j" hwp:id="sec-20"><title hwp:id="title-27">Overlapping analysis for copy number segmentations estimated from different tools</title><p hwp:id="p-71">To evaluate the performance, the copy number segmentation estimated from sCNAphase was compared with those from CLImAT and COSMIC by overlapping the estimated varied criteria. The overall performance was calculated by comparing how many bases were consistently estimated as gain or loss for any two segmentations. In the same way, the consistency in estimation of LOHs was also counted by per base. For the analysis of the focal sCNAs, a consistent sCNAs is considered if there are at least 50% overlap between two estimated segments. A segment is treated as focal if it is shorter than 4 Mb. We applied this different criteria for focal sCNAs because this per base overlapping criteria is unfair for the relatively shorter focal sCNAs than the longer ones. We choose 4 Mb as the threshold for focal sCNAs because the breakpoints for a focal sCNAs is likely to be inaccurate, given that all the copy number segmentations used in this paper are imputed based on the copy number at the SNPs. Therefore if an sCNAs is 2Mb in length, the estimation of 2.5Mb is still a reasonable estimation. Since the PHF in 90% of the cases spans over a region at 100K (<bold>Supplementary Figure</bold> 8), we choose this value as the low bound for the focal events.</p></sec></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-28">Acknowledgments</title><p hwp:id="p-72">The work was supported by Cancer Council Queensland grant APP1085786 awarded to Dr Lachlan J.M. Coin and UQ-CSC scholarship awarded to Wenhan Chen. We appreciate the WGS data from TCGA consortium, in particular, Dr Adam Ewing for creating the tumor-normal mixtures for HCC1143 and HCC1954. We would also like to thank Illumina BaseSpace for providing the WGS data for HCC1187 and HCC2218, COSMIC server for providing the array-based copy number profiles, and Dr Paul Edwards for the SKY plots. We thank Haojing Shao for analyzing the patterns of the somatic copy number alterations, Dr Sarah Song for collecting the sequencing data and Dr Alison Anderson for reviewing and commenting on the current study.</p></ack><ref-list hwp:id="ref-list-1"><title hwp:id="title-29">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Altshuler D"><surname>Altshuler</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Durbin R"><surname>Durbin</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Abecasis G"><surname>Abecasis</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bentley D"><surname>Bentley</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chakravarti A"><surname>Chakravarti</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Clark A"><surname>Clark</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Donnelly P"><surname>Donnelly</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eichler E"><surname>Eichler</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Flicek P"><surname>Flicek</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gabriel S"><surname>Gabriel</surname> <given-names>S</given-names></string-name>. <year>2012</year>. <article-title hwp:id="article-title-2">An integrated map of genetic variation from 1,092 human genomes</article-title>. <source hwp:id="source-1">NATURE</source> <volume>491</volume>(<issue>7422</issue>): <fpage>56</fpage>–<lpage>65</lpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.2" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Aran D"><surname>Aran</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sirota M"><surname>Sirota</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Butte AJ"><surname>Butte</surname> <given-names>AJ</given-names></string-name>. <year>2015</year>. <article-title hwp:id="article-title-3">Systematic pan-cancer analysis of tumour purity</article-title>. <source hwp:id="source-2">Nat Commun</source> <volume>6</volume>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Bambury RM"><surname>Bambury</surname> <given-names>RM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bhatt AS"><surname>Bhatt</surname> <given-names>AS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Riester M"><surname>Riester</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pedamallu CS"><surname>Pedamallu</surname> <given-names>CS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Duke F"><surname>Duke</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bellmunt J"><surname>Bellmunt</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stack EC"><surname>Stack</surname> <given-names>EC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Werner L"><surname>Werner</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Park R"><surname>Park</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Iyer G"><surname>Iyer</surname> <given-names>G</given-names></string-name> <etal>et al.</etal> <year>2015</year>. <article-title hwp:id="article-title-4">DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors</article-title>. <source hwp:id="source-3">BMC Cancer</source> <volume>15</volume>(<issue>1</issue>): <fpage>242</fpage>–<lpage>242</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Bast RC"><surname>Bast</surname> <given-names>RC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ravdin P"><surname>Ravdin</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hayes DF"><surname>Hayes</surname> <given-names>DF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bates S"><surname>Bates</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fritsche H"><surname>Fritsche</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jessup JM"><surname>Jessup</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kemeny N"><surname>Kemeny</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Locker GY"><surname>Locker</surname> <given-names>GY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mennel RG"><surname>Mennel</surname> <given-names>RG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Somerfield MR"><surname>Somerfield</surname> <given-names>MR</given-names></string-name>. <year>2001</year>. <article-title hwp:id="article-title-5">2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*</article-title>. <source hwp:id="source-4">Journal of Clinical Oncology</source> <volume>19</volume>(<issue>6</issue>): <fpage>1865</fpage>–<lpage>1878</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Beroukhim R"><surname>Beroukhim</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mermel CH"><surname>Mermel</surname> <given-names>CH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Porter D"><surname>Porter</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wei G"><surname>Wei</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raychaudhuri S"><surname>Raychaudhuri</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Donovan J"><surname>Donovan</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barretina J"><surname>Barretina</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Boehm JS"><surname>Boehm</surname> <given-names>JS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dobson J"><surname>Dobson</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Urashima M"><surname>Urashima</surname> <given-names>M</given-names></string-name> <etal>et al.</etal> <year>2010</year>. <article-title hwp:id="article-title-6">The landscape of somatic copy-number alteration across human cancers</article-title>. <source hwp:id="source-5">Nature</source> <volume>463</volume>(<issue>7283</issue>): <fpage>899905</fpage>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Boeva V"><surname>Boeva</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Popova T"><surname>Popova</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bleakley K"><surname>Bleakley</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chiche P"><surname>Chiche</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cappo J"><surname>Cappo</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schleiermacher G"><surname>Schleiermacher</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Janoueix-Lerosey I"><surname>Janoueix-Lerosey</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Delattre O"><surname>Delattre</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barillot E"><surname>Barillot</surname> <given-names>E</given-names></string-name>. <year>2012</year>. <article-title hwp:id="article-title-7">Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data</article-title>. <source hwp:id="source-6">Bioinformatics</source> <volume>28</volume>(<issue>3</issue>): <fpage>423</fpage>–<lpage>425</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Cairns P"><surname>Cairns</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Polascik TJ"><surname>Polascik</surname> <given-names>TJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eby Y"><surname>Eby</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tokino K"><surname>Tokino</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Califano J"><surname>Califano</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Merlo A"><surname>Merlo</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mao L"><surname>Mao</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Herath J"><surname>Herath</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jenkins R"><surname>Jenkins</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Westra W"><surname>Westra</surname> <given-names>W</given-names></string-name> <etal>et al.</etal> <year>1995</year>. <article-title hwp:id="article-title-8">Frequency of homozygous deletion at p16/CDKN2 in primary human tumours</article-title>. <source hwp:id="source-7">Nat Genet</source> <volume>11</volume>(<issue>2</issue>): <fpage>210</fpage>–<lpage>212</lpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2 xref-ref-8-3 xref-ref-8-4 xref-ref-8-5 xref-ref-8-6"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Carter SL"><surname>Carter</surname> <given-names>SL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cibulskis K"><surname>Cibulskis</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Helman E"><surname>Helman</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="McKenna A"><surname>McKenna</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shen H"><surname>Shen</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zack T"><surname>Zack</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Laird PW"><surname>Laird</surname> <given-names>PW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Onofrio RC"><surname>Onofrio</surname> <given-names>RC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Winckler W"><surname>Winckler</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weir Ba"><surname>Weir</surname> <given-names>Ba</given-names></string-name> <etal>et al.</etal> <year>2012</year>. <article-title hwp:id="article-title-9">Absolute quantification of somatic DNA alterations in human cancer</article-title>. <source hwp:id="source-8">Nature biotechnology</source> <volume>30</volume>(<issue>5</issue>): <fpage>413</fpage>–<lpage>421</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Carter SL"><surname>Carter</surname> <given-names>SL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eklund AC"><surname>Eklund</surname> <given-names>AC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kohane IS"><surname>Kohane</surname> <given-names>IS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Harris LN"><surname>Harris</surname> <given-names>LN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Szallasi Z"><surname>Szallasi</surname> <given-names>Z</given-names></string-name>. <year>2006</year>. <article-title hwp:id="article-title-10">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</article-title>. <source hwp:id="source-9">Nature genetics</source> <volume>38</volume>(<issue>9</issue>): <fpage>1043</fpage>–<lpage>1048</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Chin K"><surname>Chin</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="DeVries S"><surname>DeVries</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fridlyand J"><surname>Fridlyand</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Spellman PT"><surname>Spellman</surname> <given-names>PT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Roydasgupta R"><surname>Roydasgupta</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kuo W-L"><surname>Kuo</surname> <given-names>W-L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lapuk A"><surname>Lapuk</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neve RM"><surname>Neve</surname> <given-names>RM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Qian Z"><surname>Qian</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ryder T"><surname>Ryder</surname> <given-names>T</given-names></string-name> <etal>et al.</etal> <year>2006</year>. <article-title hwp:id="article-title-11">Genomic and transcriptional aberrations linked to breast cancer pathophysiologies</article-title>. <source hwp:id="source-10">Cancer cell</source> <volume>10</volume>(<issue>6</issue>): <fpage>529</fpage>–<lpage>541</lpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Cho Y-J"><surname>Cho</surname> <given-names>Y-J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tsherniak A"><surname>Tsherniak</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tamayo P"><surname>Tamayo</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Santagata S"><surname>Santagata</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ligon A"><surname>Ligon</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Greulich H"><surname>Greulich</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Berhoukim R"><surname>Berhoukim</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Amani V"><surname>Amani</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goumnerova L"><surname>Goumnerova</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eberhart CG"><surname>Eberhart</surname> <given-names>CG</given-names></string-name> <etal>et al.</etal> <year>2011</year>. <article-title hwp:id="article-title-12">Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome</article-title>. <source hwp:id="source-11">Journal of the American Society of Clinical Oncology</source> <volume>29</volume>(<issue>11</issue>): <fpage>1424</fpage>–<lpage>1430</lpage>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Coin LJ"><surname>Coin</surname> <given-names>LJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Asher JE"><surname>Asher</surname> <given-names>JE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Walters RG"><surname>Walters</surname> <given-names>RG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Moustafa JSE-S"><surname>Moustafa</surname> <given-names>JSE-S</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Smith AJ"><surname>de Smith</surname> <given-names>AJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sladek R"><surname>Sladek</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Balding DJ"><surname>Balding</surname> <given-names>DJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Froguel P"><surname>Froguel</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Blakemore AI"><surname>Blakemore</surname> <given-names>AI</given-names></string-name>. <year>2010</year>. <article-title hwp:id="article-title-13">cnvHap: an integrative population and haplotype-based multiplatform model of SNPs and CNVs</article-title>. <source hwp:id="source-12">Nature methods</source> <volume>7</volume>(<issue>7</issue>): <fpage>541</fpage>–<lpage>546</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Conrad DF"><surname>Conrad</surname> <given-names>DF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pinto D"><surname>Pinto</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Redon R"><surname>Redon</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Feuk L"><surname>Feuk</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gokcumen O"><surname>Gokcumen</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang Y"><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aerts J"><surname>Aerts</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Andrews TD"><surname>Andrews</surname> <given-names>TD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barnes C"><surname>Barnes</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Campbell P"><surname>Campbell</surname> <given-names>P</given-names></string-name> <etal>et al.</etal> <year>2010</year>. <article-title hwp:id="article-title-14">Origins and functional impact of copy number variation in the human genome</article-title>. <source hwp:id="source-13">Nature</source> <volume>464</volume>(<issue>7289</issue>): <fpage>704</fpage>–<lpage>712</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Curtis C"><surname>Curtis</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shah SP"><surname>Shah</surname> <given-names>SP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chin S-F"><surname>Chin</surname> <given-names>S-F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Turashvili G"><surname>Turashvili</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rueda OM"><surname>Rueda</surname> <given-names>OM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dunning MJ"><surname>Dunning</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Speed D"><surname>Speed</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lynch AG"><surname>Lynch</surname> <given-names>AG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Samarajiwa S"><surname>Samarajiwa</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yuan Y"><surname>Yuan</surname> <given-names>Y</given-names></string-name> <etal>et al.</etal> <year>2012</year>. <article-title hwp:id="article-title-15">The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups</article-title>. <source hwp:id="source-14">Nature</source> <volume>486</volume>(<issue>7403</issue>): <fpage>346</fpage>–<lpage>352</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1 xref-ref-15-2 xref-ref-15-3 xref-ref-15-4"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Delaneau O"><surname>Delaneau</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Howie B"><surname>Howie</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cox AJ"><surname>Cox</surname> <given-names>AJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zagury J-F"><surname>Zagury</surname> <given-names>J-F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marchini J"><surname>Marchini</surname> <given-names>J</given-names></string-name>. <year>2013</year>. <article-title hwp:id="article-title-16">Haplotype estimation using sequencing reads</article-title>. <source hwp:id="source-15">American journal of human genetics</source> <volume>93</volume>(<issue>4</issue>): <fpage>687</fpage>–<lpage>696</lpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Desnoyers LR"><surname>Desnoyers</surname> <given-names>LR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pai R"><surname>Pai</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ferrando RE"><surname>Ferrando</surname> <given-names>RE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hotzel K"><surname>Hotzel</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Le T"><surname>Le</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ross J"><surname>Ross</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carano R"><surname>Carano</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="D’Souza A"><surname>D’Souza</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Qing J"><surname>Qing</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mohtashemi I"><surname>Mohtashemi</surname> <given-names>I</given-names></string-name> <etal>et al.</etal> <year>2007</year>. <article-title hwp:id="article-title-17">Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models</article-title>. <source hwp:id="source-16">Oncogene</source> <volume>27</volume>(<issue>1</issue>): <fpage>85</fpage>–<lpage>97</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Forbes SA"><surname>Forbes</surname> <given-names>SA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Beare D"><surname>Beare</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gunasekaran P"><surname>Gunasekaran</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leung K"><surname>Leung</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bindal N"><surname>Bindal</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Boutselakis H"><surname>Boutselakis</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ding M"><surname>Ding</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bamford S"><surname>Bamford</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cole C"><surname>Cole</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ward S"><surname>Ward</surname> <given-names>S</given-names></string-name> <etal>et al.</etal> <year>2015</year>. <article-title hwp:id="article-title-18">COSMIC: exploring the world’s knowledge of somatic mutations in human cancer</article-title>. <source hwp:id="source-17">Nucleic Acids Research</source> <volume>43</volume>(<issue>D1</issue>): <fpage>D805</fpage>–<lpage>D811</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Goya R"><surname>Goya</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sun MG"><surname>Sun</surname> <given-names>MG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Morin RD"><surname>Morin</surname> <given-names>RD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leung G"><surname>Leung</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ha G"><surname>Ha</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wiegand KC"><surname>Wiegand</surname> <given-names>KC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Senz J"><surname>Senz</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Crisan A"><surname>Crisan</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marra MA"><surname>Marra</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hirst M"><surname>Hirst</surname> <given-names>M</given-names></string-name>. <year>2010</year>. <article-title hwp:id="article-title-19">SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors</article-title>. <source hwp:id="source-18">Bioinformatics</source> <volume>26</volume>(<issue>6</issue>): <fpage>730</fpage>–<lpage>736</lpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Greenman CD"><surname>Greenman</surname> <given-names>CD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bignell G"><surname>Bignell</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Butler A"><surname>Butler</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Edkins S"><surname>Edkins</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hinton J"><surname>Hinton</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Beare D"><surname>Beare</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Swamy S"><surname>Swamy</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Santarius T"><surname>Santarius</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen L"><surname>Chen</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Widaa S"><surname>Widaa</surname> <given-names>S</given-names></string-name>. <year>2010</year>. <article-title hwp:id="article-title-20">PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data</article-title>. <source hwp:id="source-19">Biostatistics</source> <volume>11</volume>(<issue>1</issue>): <fpage>164</fpage>–<lpage>175</lpage>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1 xref-ref-20-2"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Grigorova M"><surname>Grigorova</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lyman RC"><surname>Lyman</surname> <given-names>RC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Caldas C"><surname>Caldas</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Edwards PAW"><surname>Edwards</surname> <given-names>PAW</given-names></string-name>. <year>2005</year>. <article-title hwp:id="article-title-21">Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping</article-title>. <source hwp:id="source-20">Cancer Genetics and Cytogenetics</source> <volume>162</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Gusnanto A"><surname>Gusnanto</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wood HM"><surname>Wood</surname> <given-names>HM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pawitan Y"><surname>Pawitan</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rabbitts P"><surname>Rabbitts</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Berri S"><surname>Berri</surname> <given-names>S</given-names></string-name>. <year>2012</year>. <article-title hwp:id="article-title-22">Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data</article-title>. <source hwp:id="source-21">Bioinformatics</source> <volume>28</volume>(<issue>1</issue>): <fpage>40</fpage>–<lpage>47</lpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Hieronymus H"><surname>Hieronymus</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schultz N"><surname>Schultz</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gopalan A"><surname>Gopalan</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carver BS"><surname>Carver</surname> <given-names>BS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chang MT"><surname>Chang</surname> <given-names>MT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xiao Y"><surname>Xiao</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heguy A"><surname>Heguy</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huberman K"><surname>Huberman</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bernstein M"><surname>Bernstein</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Assel M"><surname>Assel</surname> <given-names>M</given-names></string-name> <etal>et al.</etal> <year>2014</year>. <article-title hwp:id="article-title-23">Copy number alteration burden predicts prostate cancer relapse</article-title>. <source hwp:id="source-22">Proceedings of the National Academy of Sciences</source> <volume>111</volume>(<issue>30</issue>): <fpage>11139</fpage>–<lpage>11144</lpage>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1 xref-ref-23-2"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Kao J"><surname>Kao</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Salari K"><surname>Salari</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bocanegra M"><surname>Bocanegra</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Choi Y-L"><surname>Choi</surname> <given-names>Y-L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Girard L"><surname>Girard</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gandhi J"><surname>Gandhi</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kwei KA"><surname>Kwei</surname> <given-names>KA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hernandez-Boussard T"><surname>Hernandez-Boussard</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang P"><surname>Wang</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gazdar AF"><surname>Gazdar</surname> <given-names>AF</given-names></string-name> <etal>et al.</etal> <year>2009</year>. <article-title hwp:id="article-title-24">Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery</article-title>. <source hwp:id="source-23">PLoS ONE</source> <volume>4</volume>(<issue>7</issue>): <fpage>e6146</fpage>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Keller G"><surname>Keller</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vogelsang H"><surname>Vogelsang</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Becker I"><surname>Becker</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Plaschke S"><surname>Plaschke</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ott K"><surname>Ott</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Suriano G"><surname>Suriano</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mateus AR"><surname>Mateus</surname> <given-names>AR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Seruca R"><surname>Seruca</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Biedermann K"><surname>Biedermann</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huntsman D"><surname>Huntsman</surname> <given-names>D</given-names></string-name>. <year>2004</year>. <article-title hwp:id="article-title-25">Germline mutations of the E-cadherin (CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients</article-title>. <source hwp:id="source-24">Journal of medical genetics</source> <volume>41</volume>(<issue>6</issue>): <fpage>e89</fpage>–<lpage>e89</lpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Knudson AG"><surname>Knudson</surname> <given-names>AG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hethcote HW"><surname>Hethcote</surname> <given-names>HW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brown BW"><surname>Brown</surname> <given-names>BW</given-names></string-name>. <year>1975</year>. <article-title hwp:id="article-title-26">Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma</article-title>. <source hwp:id="source-25">Proceedings of the National Academy of Sciences</source> <volume>72</volume>(<issue>12</issue>): <fpage>5116</fpage>–<lpage>5120</lpage>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Krijgsman O"><surname>Krijgsman</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carvalho B"><surname>Carvalho</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Meijer Ga"><surname>Meijer</surname> <given-names>Ga</given-names></string-name>, <string-name name-style="western" hwp:sortable="Steenbergen RDM"><surname>Steenbergen</surname> <given-names>RDM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ylstra B"><surname>Ylstra</surname> <given-names>B</given-names></string-name>. <year>2014</year>. <article-title hwp:id="article-title-27">Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack</article-title>. <source hwp:id="source-26">Biochimica et biophysica acta</source> <volume>1843</volume>(<issue>11</issue>): <fpage>2698</fpage>–<lpage>2704</lpage>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Lee AJX"><surname>Lee</surname> <given-names>AJX</given-names></string-name>, <string-name name-style="western" hwp:sortable="Endesfelder D"><surname>Endesfelder</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rowan AJ"><surname>Rowan</surname> <given-names>AJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Walther A"><surname>Walther</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Birkbak NJ"><surname>Birkbak</surname> <given-names>NJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Futreal PA"><surname>Futreal</surname> <given-names>PA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Downward J"><surname>Downward</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Szallasi Z"><surname>Szallasi</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tomlinson IPM"><surname>Tomlinson</surname> <given-names>IPM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Howell M"><surname>Howell</surname> <given-names>M</given-names></string-name> <etal>et al.</etal> <year>2011</year>. <article-title hwp:id="article-title-28">Chromosomal instability confers intrinsic multidrug resistance</article-title>. <source hwp:id="source-27">Cancer research</source> <volume>71</volume>(<issue>5</issue>): <fpage>1858</fpage>–<lpage>1870</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Li J"><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yen C"><surname>Yen</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liaw D"><surname>Liaw</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Podsypanina K"><surname>Podsypanina</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bose S"><surname>Bose</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang SI"><surname>Wang</surname> <given-names>SI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Puc J"><surname>Puc</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Miliaresis C"><surname>Miliaresis</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rodgers L"><surname>Rodgers</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="McCombie R"><surname>McCombie</surname> <given-names>R</given-names></string-name> <etal>et al.</etal> <year>1997</year>. <article-title hwp:id="article-title-29">PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer</article-title>. <source hwp:id="source-28">Science</source> <volume>275</volume>(<issue>5308</issue>): <fpage>1943</fpage>–<lpage>1947</lpage>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Li Y"><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xie X"><surname>Xie</surname> <given-names>X</given-names></string-name>. <year>2014</year>. <article-title hwp:id="article-title-30">Deconvolving tumor purity and ploidy by integrating copy number alterations and loss of heterozygosity</article-title>. <source hwp:id="source-29">Bioinformatics</source> <volume>30</volume>(<issue>15</issue>): <fpage>2121</fpage>–<lpage>2129</lpage>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Lips EH"><surname>Lips</surname> <given-names>EH</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Graaf EJ"><surname>de Graaf</surname> <given-names>EJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tollenaar R"><surname>Tollenaar</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Eijk R"><surname>van Eijk</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Oosting J"><surname>Oosting</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Szuhai K"><surname>Szuhai</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Karsten T"><surname>Karsten</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nanya Y"><surname>Nanya</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ogawa S"><surname>Ogawa</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="van de Velde CJ"><surname>van de Velde</surname> <given-names>CJ</given-names></string-name> <etal>et al.</etal> <year>2007</year>. <article-title hwp:id="article-title-31">Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomas</article-title>. <source hwp:id="source-30">The Journal of Pathology</source> <volume>212</volume>(<issue>3</issue>): <fpage>269</fpage>–<lpage>277</lpage>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Manoukian S"><surname>Manoukian</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Peissel B"><surname>Peissel</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pensotti V"><surname>Pensotti</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barile M"><surname>Barile</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cortesi L"><surname>Cortesi</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stacchiotti S"><surname>Stacchiotti</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Terenziani M"><surname>Terenziani</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barbera F"><surname>Barbera</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pasquini G"><surname>Pasquini</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frigerio S"><surname>Frigerio</surname> <given-names>S</given-names></string-name> <etal>et al.</etal> <year>2007</year>. <article-title hwp:id="article-title-32">Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families</article-title>. <source hwp:id="source-31">European Journal of Cancer</source> <volume>43</volume>(<issue>3</issue>): <fpage>601</fpage>–<lpage>606</lpage>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Mayrhofer M"><surname>Mayrhofer</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="DiLorenzo S"><surname>DiLorenzo</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Isaksson A"><surname>Isaksson</surname> <given-names>A</given-names></string-name>. <year>2013</year>. <article-title hwp:id="article-title-33">Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue</article-title>. <source hwp:id="source-32">Genome Biol</source> <volume>14</volume>(<issue>3</issue>): <fpage>R24</fpage>.</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Mullighan CG"><surname>Mullighan</surname> <given-names>CG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goorha S"><surname>Goorha</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Radtke I"><surname>Radtke</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Miller CB"><surname>Miller</surname> <given-names>CB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Coustan-Smith E"><surname>Coustan-Smith</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dalton JD"><surname>Dalton</surname> <given-names>JD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Girtman K"><surname>Girtman</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mathew S"><surname>Mathew</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ma J"><surname>Ma</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pounds SB"><surname>Pounds</surname> <given-names>SB</given-names></string-name> <etal>et al.</etal> <year>2007</year>. <article-title hwp:id="article-title-34">Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia</article-title>. <source hwp:id="source-33">Nature</source> <volume>446</volume>(<issue>7137</issue>): <fpage>758</fpage>–<lpage>764</lpage>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1 xref-ref-34-2 xref-ref-34-3"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Murthy SK"><surname>Murthy</surname> <given-names>SK</given-names></string-name>, <string-name name-style="western" hwp:sortable="DiFrancesco LM"><surname>DiFrancesco</surname> <given-names>LM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ogilvie RT"><surname>Ogilvie</surname> <given-names>RT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Demetrick DJ"><surname>Demetrick</surname> <given-names>DJ</given-names></string-name>. <year>2002</year>. <article-title hwp:id="article-title-35">Loss of Heterozygosity Associated with Uniparental Disomy in Breast Carcinoma</article-title>. <source hwp:id="source-34">Mod Pathol</source> <volume>15</volume>(<issue>12</issue>): <fpage>1241</fpage>–<lpage>1250</lpage>.</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1 xref-ref-35-2"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Neve RM"><surname>Neve</surname> <given-names>RM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chin K"><surname>Chin</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fridlyand J"><surname>Fridlyand</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yeh J"><surname>Yeh</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Baehner FL"><surname>Baehner</surname> <given-names>FL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fevr T"><surname>Fevr</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Clark L"><surname>Clark</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bayani N"><surname>Bayani</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Coppe J-P"><surname>Coppe</surname> <given-names>J-P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tong F"><surname>Tong</surname> <given-names>F</given-names></string-name> <etal>et al.</etal> <year>2006</year>. <article-title hwp:id="article-title-36">A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes</article-title>. <source hwp:id="source-35">Cancer Cell</source> <volume>10</volume>(<issue>6</issue>): <fpage>515</fpage>–<lpage>527</lpage>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.36" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Newman AM"><surname>Newman</surname> <given-names>AM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bratman SV"><surname>Bratman</surname> <given-names>SV</given-names></string-name>, <string-name name-style="western" hwp:sortable="To J"><surname>To</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wynne JF"><surname>Wynne</surname> <given-names>JF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eclov NCW"><surname>Eclov</surname> <given-names>NCW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Modlin LA"><surname>Modlin</surname> <given-names>LA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu CL"><surname>Liu</surname> <given-names>CL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neal JW"><surname>Neal</surname> <given-names>JW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wakelee HA"><surname>Wakelee</surname> <given-names>HA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Merritt RE"><surname>Merritt</surname> <given-names>RE</given-names></string-name>. <year>2014</year>. <article-title hwp:id="article-title-37">An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage</article-title>. <source hwp:id="source-36">Nature medicine</source>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Oesper L"><surname>Oesper</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Satas G"><surname>Satas</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raphael BJ"><surname>Raphael</surname> <given-names>BJ</given-names></string-name>. <year>2014</year>. <article-title hwp:id="article-title-38">Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data</article-title>. <source hwp:id="source-37">Bioinformatics</source> <volume>30</volume>(<issue>24</issue>): <fpage>3532</fpage>–<lpage>3540</lpage>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Pedersen BS"><surname>Pedersen</surname> <given-names>BS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Konstantinopoulos PA"><surname>Konstantinopoulos</surname> <given-names>PA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Spillman MA"><surname>Spillman</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="De S"><surname>De</surname> <given-names>S</given-names></string-name>. <year>2013</year>. <article-title hwp:id="article-title-39">Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients</article-title>. <source hwp:id="source-38">Genes, Chromosomes and Cancer</source> <volume>52</volume>(<issue>9</issue>): <fpage>794</fpage>–<lpage>801</lpage>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Pinto D"><surname>Pinto</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Darvishi K"><surname>Darvishi</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shi X"><surname>Shi</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rajan D"><surname>Rajan</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rigler D"><surname>Rigler</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fitzgerald T"><surname>Fitzgerald</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lionel AC"><surname>Lionel</surname> <given-names>AC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thiruvahindrapuram B"><surname>Thiruvahindrapuram</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="MacDonald JR"><surname>MacDonald</surname> <given-names>JR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mills R"><surname>Mills</surname> <given-names>R</given-names></string-name>. <year>2011</year>. <article-title hwp:id="article-title-40">Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants</article-title>. <source hwp:id="source-39">Nature biotechnology</source> <volume>29</volume>(<issue>6</issue>): <fpage>512</fpage>–<lpage>520</lpage>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Sawey Eric T"><surname>Sawey Eric</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chanrion M"><surname>Chanrion</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cai C"><surname>Cai</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu G"><surname>Wu</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang J"><surname>Zhang</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zender L"><surname>Zender</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhao A"><surname>Zhao</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Busuttil Ronald W"><surname>Busuttil Ronald</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yee H"><surname>Yee</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stein L"><surname>Stein</surname> <given-names>L</given-names></string-name> <etal>et al.</etal> <year>2011</year>. <article-title hwp:id="article-title-41">Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening</article-title>. <source hwp:id="source-40">Cancer Cell</source> <volume>19</volume>(<issue>3</issue>): <fpage>347</fpage>–<lpage>358</lpage>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Schröck E"><surname>Schröck</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Manoir Sd"><surname>Manoir</surname> <given-names>Sd</given-names></string-name>, <string-name name-style="western" hwp:sortable="Veldman T"><surname>Veldman</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schoell B"><surname>Schoell</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wienberg J"><surname>Wienberg</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ferguson-Smith MA"><surname>Ferguson-Smith</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ning Y"><surname>Ning</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ledbetter DH"><surname>Ledbetter</surname> <given-names>DH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bar-Am I"><surname>Bar-Am</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Soenksen D"><surname>Soenksen</surname> <given-names>D</given-names></string-name> <etal>et al.</etal> <year>1996</year>. <article-title hwp:id="article-title-42">Multicolor Spectral Karyotyping of Human Chromosomes</article-title>. <source hwp:id="source-41">Science</source> <volume>273</volume>(<issue>5274</issue>): <fpage>494</fpage>–<lpage>497</lpage>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1 xref-ref-42-2"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Sheffer M"><surname>Sheffer</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bacolod MD"><surname>Bacolod</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zuk O"><surname>Zuk</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Giardina SF"><surname>Giardina</surname> <given-names>SF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pincas H"><surname>Pincas</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barany F"><surname>Barany</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Paty PB"><surname>Paty</surname> <given-names>PB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gerald WL"><surname>Gerald</surname> <given-names>WL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Notterman Da"><surname>Notterman</surname> <given-names>Da</given-names></string-name>, <string-name name-style="western" hwp:sortable="Domany E"><surname>Domany</surname> <given-names>E</given-names></string-name>. <year>2009</year>. <article-title hwp:id="article-title-43">Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer</article-title>. <source hwp:id="source-42">Proceedings of the National Academy of Sciences</source> <volume>106</volume>(<issue>17</issue>): <fpage>7131</fpage>–<lpage>7136</lpage>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Side L"><surname>Side</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Taylor B"><surname>Taylor</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cayouette M"><surname>Cayouette</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Conner E"><surname>Conner</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thompson P"><surname>Thompson</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Luce M"><surname>Luce</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shannon K"><surname>Shannon</surname> <given-names>K</given-names></string-name>. <year>1997</year>. <article-title hwp:id="article-title-44">Homozygous Inactivation of the NF1 Gene in Bone Marrow Cells from Children with Neurofibromatosis Type 1 and Malignant Myeloid Disorders</article-title>. <source hwp:id="source-43">New England Journal of Medicine</source> <volume>336</volume>(<issue>24</issue>): <fpage>1713</fpage>–<lpage>1720</lpage>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Sirivatanauksorn V"><surname>Sirivatanauksorn</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sirivatanauksorn Y"><surname>Sirivatanauksorn</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gorman PA"><surname>Gorman</surname> <given-names>PA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Davidson JM"><surname>Davidson</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sheer D"><surname>Sheer</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Moore PS"><surname>Moore</surname> <given-names>PS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Scarpa A"><surname>Scarpa</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Edwards PAW"><surname>Edwards</surname> <given-names>PAW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lemoine NR"><surname>Lemoine</surname> <given-names>NR</given-names></string-name>. <year>2001</year>. <article-title hwp:id="article-title-45">Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping</article-title>. <source hwp:id="source-44">International journal of cancer</source> <volume>91</volume>(<issue>3</issue>): <fpage>350</fpage>–<lpage>358</lpage>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Slamon DJ"><surname>Slamon</surname> <given-names>DJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leyland-Jones B"><surname>Leyland-Jones</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shak S"><surname>Shak</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fuchs H"><surname>Fuchs</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Paton V"><surname>Paton</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bajamonde A"><surname>Bajamonde</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fleming T"><surname>Fleming</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eiermann W"><surname>Eiermann</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wolter J"><surname>Wolter</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pegram M"><surname>Pegram</surname> <given-names>M</given-names></string-name> <etal>et al.</etal> <year>2001</year>. <article-title hwp:id="article-title-46">Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2</article-title>. <source hwp:id="source-45">New England Journal of Medicine</source> <volume>344</volume>(<issue>11</issue>): <fpage>783</fpage>–<lpage>792</lpage>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Stephens PJ"><surname>Stephens</surname> <given-names>PJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Greenman CD"><surname>Greenman</surname> <given-names>CD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fu B"><surname>Fu</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yang F"><surname>Yang</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bignell GR"><surname>Bignell</surname> <given-names>GR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mudie LJ"><surname>Mudie</surname> <given-names>LJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pleasance ED"><surname>Pleasance</surname> <given-names>ED</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lau KW"><surname>Lau</surname> <given-names>KW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Beare D"><surname>Beare</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stebbings La"><surname>Stebbings</surname> <given-names>La</given-names></string-name> <etal>et al.</etal> <year>2011</year>. <article-title hwp:id="article-title-47">Massive genomic rearrangement acquired in a single catastrophic event during cancer development</article-title>. <source hwp:id="source-46">Cell</source> <volume>144</volume>(<issue>1</issue>): <fpage>27</fpage>–<lpage>40</lpage>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Storlazzi CT"><surname>Storlazzi</surname> <given-names>CT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lonoce A"><surname>Lonoce</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Guastadisegni MC"><surname>Guastadisegni</surname> <given-names>MC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trombetta D"><surname>Trombetta</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="D’Addabbo P"><surname>D’Addabbo</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Daniele G"><surname>Daniele</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="L’Abbate A"><surname>L’Abbate</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Macchia G"><surname>Macchia</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Surace C"><surname>Surace</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kok K"><surname>Kok</surname> <given-names>K</given-names></string-name> <etal>et al.</etal> <year>2010</year>. <article-title hwp:id="article-title-48">Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure</article-title>. <source hwp:id="source-47">Genome research</source> <volume>20</volume>(<issue>9</issue>): <fpage>1198</fpage>–<lpage>1206</lpage>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1 xref-ref-48-2 xref-ref-48-3"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Tuna M"><surname>Tuna</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Knuutila S"><surname>Knuutila</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mills GB"><surname>Mills</surname> <given-names>GB</given-names></string-name>. <year>2009</year>. <article-title hwp:id="article-title-49">Uniparental disomy in cancer</article-title>. <source hwp:id="source-48">Trends in Molecular Medicine</source> <volume>15</volume>(<issue>3</issue>): <fpage>120</fpage>–<lpage>128</lpage>.</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Whibley C"><surname>Whibley</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pharoah PDP"><surname>Pharoah</surname> <given-names>PDP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hollstein M"><surname>Hollstein</surname> <given-names>M</given-names></string-name>. <year>2009</year>. <article-title hwp:id="article-title-50">p53 polymorphisms: cancer implications</article-title>. <source hwp:id="source-49">Nat Rev Cancer</source> <volume>9</volume>(<issue>2</issue>): <fpage>95</fpage>–<lpage>107</lpage>.</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1 xref-ref-50-2"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.50" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Wilks C"><surname>Wilks</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cline MS"><surname>Cline</surname> <given-names>MS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weiler E"><surname>Weiler</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Diehkans M"><surname>Diehkans</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Craft B"><surname>Craft</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Martin C"><surname>Martin</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Murphy D"><surname>Murphy</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pierce H"><surname>Pierce</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Black J"><surname>Black</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nelson D"><surname>Nelson</surname> <given-names>D</given-names></string-name> <etal>et al.</etal> <year>2014</year>. <article-title hwp:id="article-title-51">The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data</article-title>. <source hwp:id="source-50">Database: the journal of biological databases and curation 2014</source>.</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Yau C"><surname>Yau</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mouradov D"><surname>Mouradov</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jorissen RN"><surname>Jorissen</surname> <given-names>RN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Colella S"><surname>Colella</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mirza G"><surname>Mirza</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Steers G"><surname>Steers</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Harris A"><surname>Harris</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ragoussis J"><surname>Ragoussis</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sieber O"><surname>Sieber</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Holmes CC"><surname>Holmes</surname> <given-names>CC</given-names></string-name>. <year>2010</year>. <article-title hwp:id="article-title-52">A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data</article-title>. <source hwp:id="source-51">Genome biology</source> <volume>11</volume>(<issue>9</issue>): <fpage>R92</fpage>–<lpage>R92</lpage>.</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Yu Z"><surname>Yu</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu Y"><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shen Y"><surname>Shen</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang M"><surname>Wang</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li A"><surname>Li</surname> <given-names>A</given-names></string-name>. <year>2014</year>. <article-title hwp:id="article-title-53">CLImAT: accurate detection of copy number alteration and loss of heterozygosity in impure and aneuploid tumor samples using whole-genome sequencing data</article-title>. <source hwp:id="source-52">Bioinformatics</source> <volume>30</volume>(<issue>5</issue>): <fpage>413</fpage>–<lpage>421</lpage>.</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Zack TI"><surname>Zack</surname> <given-names>TI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schumacher SE"><surname>Schumacher</surname> <given-names>SE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carter SL"><surname>Carter</surname> <given-names>SL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cherniack AD"><surname>Cherniack</surname> <given-names>AD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Saksena G"><surname>Saksena</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tabak B"><surname>Tabak</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lawrence MS"><surname>Lawrence</surname> <given-names>MS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang C-Z"><surname>Zhang</surname> <given-names>C-Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wala J"><surname>Wala</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mermel CH"><surname>Mermel</surname> <given-names>CH</given-names></string-name> <etal>et al.</etal> <year>2013</year>. <article-title hwp:id="article-title-54">Pan-cancer patterns of somatic copy number alteration</article-title>. <source hwp:id="source-53">Nat Genet</source> <volume>45</volume>(<issue>10</issue>): <fpage>1134</fpage>–<lpage>1140</lpage>.</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><citation publication-type="journal" citation-type="journal" ref:id="038828v2.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Zhao X"><surname>Zhao</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li C"><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Paez JG"><surname>Paez</surname> <given-names>JG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chin K"><surname>Chin</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jänne PA"><surname>Jänne</surname> <given-names>PA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen T-H"><surname>Chen</surname> <given-names>T-H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Girard L"><surname>Girard</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Minna J"><surname>Minna</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Christiani D"><surname>Christiani</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leo C"><surname>Leo</surname> <given-names>C</given-names></string-name>. <year>2004</year>. <article-title hwp:id="article-title-55">An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays</article-title>. <source hwp:id="source-54">Cancer research</source> <volume>64</volume>(<issue>9</issue>): <fpage>3060</fpage>–<lpage>3071</lpage>.</citation></ref></ref-list></back></article>
